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Abstract 
Growth and deposition of amyloid fibrils, polymers of proteins with a cross beta-sheet 
structure, are associated with a significant number of human pathologies including Alzheimer’s 
disease, Parkinson’s disease, prion diseases, type II diabetes, and senile systematic or dialysis-
related amyloidoses. The broader objective of my research is to identify the basic mechanisms 
regulating nucleation and growth of amyloid fibrils. There is increasing evidence that amyloid 
formation may proceed along at least two distinct assembly pathways for the formation of rigid 
fibrils. One pathway involves the nucleated polymerization of the characteristic rigid fibrils from 
partially denatured monomers and the other proceeds via the growth of globular oligomers and their 
associated curvilinear fibrils (also known as protofibrils) which, in ways yet to be determined, 
transform into late-stage rigid fibrils. These oligomeric intermediates of fibril assembly, in 
particular, have been implicated as the predominant aggregate species causing cellular toxicity in 
amyloid diseases. Yet, amyloid oligomers and curvilinear fibrils are considered transient, 
metastable aggregates. This raises the question whether and how such transient aggregate species 
can be responsible for most of the cell/tissue toxicity?  
In this dissertation, I report on my investigation of several basic questions related to the 
mechanisms of amyloid formation. Using the model amyloid hen egg-white lysozyme, I 
participated in research to characterize the distinct kinetics of amyloid formation along distinct 
assembly pathways, to determine the morphological features of the various aggregate species 
emerging along either pathway, and to investigate the structural evolution of the monomers from 
their native state to the amyloid cross-β sheet structure (chapter 3). Chapters 4-6 represent the core 
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of my dissertation work.  There I investigated whether amyloid aggregates from three different 
amyloid proteins, formed under denaturing condition, could undergo prion-like proliferation upon 
return to physiological solution conditions. I was also intimately involved in a project on the 
conditions inducing amyloid spherulites formation by polyglutamic acid and the mechanisms 
resulting in the formation of this often-overlooked amyloid aggregate structure (chapter 7).   In the 
appendix I provide a short summary of the various experimental techniques I have used in the 
above experiments. 
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Chapter 1 
Background 
 
1.1. Amyloid Formation in Disease 
The aggregation of proteins into fibrils with common β-sheet architecture, called amyloid 
fibrils, underlies a broad class of human disorders collectively referred to as amyloidoses.  Amyloid 
diseases include Alzheimer’s disease, Parkinson disease, prion diseases, and type II diabetes. 
According to the world health organizations, amyloid diseases are rapidly becoming the most 
common medical conditions in the modern world [World Alzheimer report, 2010; World health 
organization and Alzheimer’s disease International, 2012]. Amyloid formation can result in the 
formation of extracellular deposits, called plaques, or intracellular deposits, called inclusion bodies 
(Huntington Disease) or tangles (tauopathies). In all cases, these deposits are associated with 
extensive tissue damage in their vicinity [Uversky et al., 1999; Ross et al., 2004;	  Chiti and Dobson 
2006]. Surprisingly, though, the specific mechanisms by which amyloid formation induces cell 
death and tissue damage are still not universally agreed upon. One leading hypothesis holds  that 
amyloid fibrils formation involves the generation of transient oligomeric species that disrupt cell 
function [Hardy et al., 2002; Chiti and Dobson 2006; Eisenberg and Jucker 2012; Walsh et al., 
2002; Campioni et al., 2010]. Similarly, a variety of proposals has been put forth to explain what 
causes the onset of amyloid formation in vivo, including increased synthesis or reduced degradation 
of a given protein, leading to an abnormal increase in its concentration [Balch et al., 2008] or the 
accumulation of oxidized protein species in age. 
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Studies of amyloid formation in vivo have linked the findings of in vitro experiments and 
the events that take place in vivo. Using FTIR spectroscopy, Jahn et al. (2008) have shown that 
amyloid fibrils of β2- microglobulin grown in vitro have the same spectral features as those isolated 
from patients with dialysis-related amyloidosis. In addition, in vitro and in vivo aggregates had 
comparable morphologies. Hence, studies of amyloid formation in vitro can provide basic and 
important insights into the molecular processes underlying amyloid formation in vivo. 
1.2. The Cross Beta-Sheet Structure of Amyloid Fibrils 
While the various proteins or proteolytic fragments that form amyloid fibrils in different 
diseases have no structural or functional similarities, the resulting amyloid fibrils share basic 
structural characteristics [Uversky, 2003; Zandomeneghi et al., 2004, Foley et al., 2013].  
Biophysicists have investigated the structure of mature fibrils using a variety of experimental 
approaches, including nuclear magnetic resonance (NMR) [Benzinger et al., 1998; Tyco, 2011], X-
ray fiber and powder diffraction [Astbury et al., 1935; Sunde and Blake, 1998; Makin et al., 2005; 
Nelson et al., 2005], site-directed labeling [Serag et al., 2001; Torok et al., 2002], cryo-EM 
[Jemenez et al., 2005; Schmidt et al., 2009], and scanning mutagenesis [Williams et al., 2005]. The 
main similarity is the shared cross-β sheet architecture of mature fibrils:  adjacent peptide segments 
in a given fibril are aligned perpendiculars to the main fibril axis, and are linked to each other by 
intermolecular hydrogen bonds between their backbones (Figure 1.1c). These β sheets can be either 
parallel or antiparallel, that is, adjacent peptide segments within a fibril are aligned in the same or in 
opposite directions. The residues of individual amino acids point perpendicularly outward from this 
main fibril axis. The overall hierarchy of a typical amyloid fibril involves stacking of β-strands into 
extended β-sheet. Two layers of β-sheets then come together to create a compact dehydrated 
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interface termed steric zipper [Eisenberg and Jucker, 2012]. A significant number of atomic 
structures of steric zippers have been determined using X-ray crystallography [Nelson et al., 2005;	  
Sawaya et al., 2007; Wiltzius et al., 2009; Cheng et al., 2012]. X-ray scattering reveals that this 
steric zippers form dry interface between adjacent sheets. The formation of this interface is 
primarily driven by van der Waals interactions, hydrogen bonds between the side chains and 
packing (steric) considerations. In addition, these fibrils can twist and come together to form thicker 
bundles (Figure 1.1a & 1.1b).  
                                                                      
 
Figure 1.1. Structure of an Amyloid Fibril at Atomic Resolution. The combination of (a&b) cry-electron 
microscopy imaging with solid state NMR has enabled the determination of an atomic level structure. White 
scale bar in electron microscopy image (a) represents 50nm; (c) A schematic of the characteristic x-ray 
diffraction pattern of an amyloid fibrils. The β-strands are organized perpendicular to the axis of the fibril, 
with an inter-strand spacing of 4.8 Ǻ. This spacing is due to the hydrogen bonding between the protein 
backbones, and is conserved among all amyloid fibrils regardless of the native structure of the protein. The 
inter-sheet spacing shows more variation. It depends on the interactions of the side chains. Typical value of 
inter-sheet spacing is about 10 Ǻ.  (d) Two layers of β-sheets come together to create a compact dehydrated 
interface termed steric zipper. (e) These steric zippers run up and down the fibril axis, excluding water from 
the space between β- sheets, indicated by the red + signs. [Source: Eisenberg and Jucker. Cell, (2012) & 
Knowles et al.,  Nature Rev. Mol. Cell. Biol., (2014)]. 
 
(a) (b) 
(c) 
(d) (e) 
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Given the shared structural characteristics of amyloid fibrils, it has been suggested that the 
mechanisms of amyloid formation have generic features due to the intrinsic propensity of any 
polypeptide chain to form intermolecular hydrogen bonds [Fandrich and Dobson, 2002].  This 
“generic” aspect of amyloid formation is one of our motivations to study amyloid formation 
through the lens of the physics of phase separation phenomena. 
 
1.3. Amyloid Oligomers, Curvilinear and Rigid Fibril Assembly Pathways 
Amyloid formation by different proteins not only results in similar fibril architectures but 
also includes the types of aggregation intermediates emerging during the fibril assembly process. 
There is increasing evidence that fibril assembly can proceed along two distinct assembly pathways 
generating distinct aggregation intermediates (Figure 1.2).  One pathway involves the formation of 
globular oligomers (aOs) and their curvilinear fibrils (CFs), sometimes called protofibrils (Figure 
1.2b), while the other pathway directly generates rigid filaments (RFs) from monomers. These rigid 
fibrils are commonly associated with the late-stages of amyloid assembly (Figure 1.2a) [Gosal et 
al., 2005; Kayed et al., 2007;  Hill et al., 2009;  Foley et al., 2013;  Miti et al., 2015]. Observations 
indicate that the amyloid oligomers, in turn, are short-lived transients of fibril assembly that often 
require extrinsic stabilization for studying their properties [Bitan, 2006]. These oligomeric 
intermediates have also been implicated as the dominant amyloid aggregate state responsible for the 
cellular toxicity associated with amyloidoses [Campioni et al., 2010; Kayed et al. 2004; Ono et al., 
2009; Klein et al., 2001; Cleary et al., 2005].  How these metastable and transient oligomers initiate 
the various pathologies associated with amyloid disease and enable their spread within tissue is not 
clear yet. While we have structural details for some of the amyloid fibrils, structural information 
about the organization of amyloid oligomers and protofibrils, which are polymeric assemblies of 
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oligomers, are still very limited. Based on structural data from small peptide fragments of the 
Alzheimer peptide A-β, amyloid oligomers assume a β-barrel-like structure [Laganowsky et al., 
2012]. 
    
Figure 1.2. Distinct Morphologies of Amyloid Aggregates Associated with Growth in vitro. Aggregates 
of lysozymes formed under partially denaturing conditions (pH 2, T = 52 °C). (a) Mixture of rigid filaments 
(orange), and wider mature fibrils (green) grown in 50 mM NaCl at pH = 2 and T = 50 0C. Both fibril 
populations are very straight and mechanically stiff; (b) late stage curvilinear fibrils (green) obtained during 
incubation of 20 mg/ml lysozyme in 200 mM NaCl. Curvilinear fibrils (CFs) are much less rigid despite 
being noticeably thicker than the stiff rigid filaments shown in (a). Black scale bar in all images represents 
300 nm,	   false color scale: height in nm. [Source: Miti, Mulaj, Schmit and Muschol, Biomacromolecules, 
(2015)]. 
 β-barrel oligomers have an antiparallel β-sheet structure aligned in a twisted cylindrical shape 
(Figure 1.3).  Each strand in this cylindrical structure (oligomer) is bound to one neighboring strand 
by a strong interface and to a second strand by a weak interface.  Pairs of strands form antiparallel 
dimers, which assemble around the axis down the barrel of axis of the cylinder (Figure 1.3b).  The 
backbone hydrogen bonds stabilize the strong interface between twisted antiparallel strands, while 
the weaker interface between the twisted strands is formed by main chain hydrogen bonds with 
additional contribution of hydrogen bonds coming from a water bridge and bonds from side chain 
interactions (Figure 1.3c).  Overall, the cylinder structure shares common features with a steric 
zipper being formed by hydrogen-bonded β strands and having a dry interior, but it is cylindrical 
rather than nearly flat. Infrared spectroscopy from several labs, including ours, provides 
 (a)                                             (b)                                           
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experimental support for this structure assignment [Cerf, Sarroukh, Tamaizu-Kato, Breydo, et al., 
2009; Foley, Hill, Miti, Mulaj, Muschol et al., 2013]  
 
Figure 1.3. Crystal Structure of Oligomers. (a) Schematic of unrolled cylinder (outside view), illustrating 
strand-to-strand registration. Hydrogen bonds between the main chains and neighboring strands shown by 
yellow dashed lines, blue dashed lines indicates hydrogen bonds of side chain or bonds mediated by water 
bridges; (b) Pairs of strands form antiparallel dimers, which assemble around the barrel  axis of the cylinder, 
and (c) the cylinder with side chains and hydrogen bonds in yellow. [Adopted from: Laganaowsky et al. 
Science. 335, 1228 (2012)].  
 
1.4. Hen-Egg White Lysozyme (HEWL) as a Model Amyloid 
Hen-Egg White Lysozyme (HEWL) is a small globular enzyme with a molecular weight of 
14,4 kDa. HEWL consists of a single chain of 129 amino acids. Its biophysical and biochemical 
properties have been extensively characterized. Upon incubation at elevated temperature, native 
HEWL will grow amyloid aggregates in both acidic and basic solution conditions [Arnaudov et al., 
2005; Mossuto et al., 2010; Foley et al., 2013]. The amino acid mutations implicated in human 
lysozyme amyloidosis occur in regions that are highly homologous with HEWL [Trexler et al., 
2007]. Point mutations in human lysozyme underlie non-neuropathic systemic forms of 
amyloidosis, with dangerous disruptions to kidney and liver function [Booth et al., 1997; Gillmore 
  (a)                                              (b) 
(c) 
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et al., 1999; Pepys et al., 1993; Girnius et al., 2012; Yazaki et al., 2003; Trexler and Nilsson 2007]. 
HEWL undergoes a well-defined cooperative unfolding transition as a function of temperature, 
thereby permitting us to generate amyloid aggregates at elevated temperature and to bring them to 
temperatures where HEWL remains native folded structure. During in vitro growth at acid pH and 
denaturing temperatures amyloid formation of lysozyme switches sharply from a filamentous to an 
oligomeric assembly pathway (Figure 1.4) upon changes in salt concentration [Hill et al., 2009], 
and/or protein concentration [Miti et al., 2015].  
 
Figure 1.4. Schematic of Assembly of Lysozyme into Distinct Amyloid Aggregates. (a) Ribbon 
representation of the native structure of lysozyme monomers. Alpha-helices are shown in green; beta-strands 
are red and irregular loops are grey. Depending on salt and/or protein concentration, lysozyme aggregates 
along two different pathways: (b)	   Early-stage oligomeric intermediates(orange/green) and (c) late stage 
curvilinear fibrils (CFs) (green) obtained during incubation of  HEWL in 175  mM NaCl at pH = 2 and T = 
50 oC; (d) Mixture of rigid filaments (orange)-taller and bundles of fibrils (green)-wider grown in 50 mM 
NaCl.	  The scale bars in all images are 250 nm.  False color height scales are identical in all images. [Source:  
Figure (a) is adopted from Protein Data Bank (PBD), Figures (b-d), I have recorded in our laboratory]. 
These two distinct assembly pathways have been reported for amyloid proteins other than 
lysozyme, most prominently amyloid-β (A-β), β2-microglobulin (β2-m), and polyglutamine [Gosal 
 
 
(a) 
(b) (c) 
 
 
(d) 
 
Lysozyme Monomers 
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et al., 2005; Kodali et al., 2007; Yong et al., 2002; Vitalis et al., 2012]. The morphologies of 
lysozyme filaments (Figure 1.4d) are clearly distinct from those of oligomers (Figure 1.4b) and 
curvilinear fibrils (Figure 1.4c). For lysozyme, both amyloid oligomers and fibrils of lysozyme have 
been implicated in cytotoxic responses, with lysozyme oligomers even replicating some of the 
neurotoxic effects of Alzheimer’s disease-causing A-β [Vieira et al., 2007; Gharibyan et al., 2007]. 
Given its biomedical relevance, its well-known biophysical properties and its ready availability, 
HEWL represents an attractive model system for studying and characterizing amyloid assembly of 
proteins. 
1.5. Thermodynamics and Kinetics of Amyloid Fibril Formation 
 Exposure and favorable interactions among the backbone amide groups of a given protein 
are considered necessary but not sufficient for the onset of amyloid formation [Uversky et al., 
2004]. In addition, the local concentration of proteins with exposed segments must be sufficient to 
overcome the entropy that opposes formation of ordered amyloid aggregates. In general, the 
aggregated amyloid fibril state is considered the conformation that is energetically favored over the 
folded state of native proteins (or the disordered monomeric state of intrinsically disordered 
proteins). However, there is a significant kinetic barrier separating the monomeric state of proteins 
from the aggregated fibrillar state (Figure 1.5).  In the case of folded proteins, this barrier involves 
the unfolding of the monomer.  Another important class of protein involved in amyloid formation 
are intrinscially disordered proteins (IDPs) which lack a well-defined tertiary and/or secondary 
structure as a whole or in part [Uversky et al., 2000; Wright et al., 1999; Uversky and Dunker, 
2010]. In the case of IDPs a partial collapse or local ordering of the proteins seems to be required 
for amyloid formation [Uversky and Longhi, 2010]. During in vitro experiments, amyloid 
aggregates are often produced from a protein by partial denaturation [Uversky et al., 2004; Uversky 
 
 
9	  
	  
 
et al., 2006]  using either a destabilizing solvent, by imposing an acidic pH, by heating, or by 
surface denaturation [Arnaudov et al., 2005; Radford et al., 2005; Hill et al., 2009; Sasahara et al., 
2007; Morgan et al., 2001]. The native state is typcially energetically less stable than the amyloid 
state [Knowles, et al., 2014].  However, two factors will determine whether a protein will enter the 
amyloid state. First, the relative equilibrium population of these two states also depends on protein 
concentration since entropy will favor the monomeric state over the aggregated fibril state. 
Formation of the fibril state therefore becomes only possible past some minimal protein 
concentration, known as critical concentration. Even then, a protein cannot make the spontaneous 
transition to the state of lower free energy due to the large energy barrier between these two states. 
If protein concentration exceeds its critical value, the protein is thermodynamically more stable in 
amyloid state. In such scenario, the native state is considered kinetically metastable state [Baldwin 
et al., 2011].      
 
Figure 1.5. Thermodynamics of Amyloid State. At a protein concentration exceeding the critical 
concentration the amyloid fibril state is thermodynamically more stable than the monomeric state.	  	  However, 
there is a significant kinetic barrier separating the native, monomeric state from the aggregated amyloid 
state.	  The difference in free energy (ΔG) between the native state and the amyloid state of conformations 
dictates the relative population of each state. [Source: Knowles et al. Nature Rev. Mol. Cell. Biol.,	  15, 384  
(2014)]. 
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1.6. Models of Amyloid Fibril Assembly 
 
To explain the mechanism of amyloid self-assembly for proteins, three major models have 
been proposed: Nucleated polymerization (NP) [Harper et al., 1997], nucleated conformational 
conversion (NCC) [Lee et al., 2011; Serio et al., 2000] and templated assembly (TA) [Griffith, 
1967]. Both NP and NCC share characteristics of phase transitions, by invoking a spontaneous 
nucleation process for the formation of a stable nucleus from partially denatured species before 
growth proceeds. In addition, both presume that at least a sub-population of the protein exists in an 
“aggregation prone” conformation.  Formation of a nucleus, however, is energetically unfavorable. 
Once the nucleus is formed, the aggregation-prone monomers can now efficiently add to it and, in 
the process, adopt the conformation of the nucleus. Consequently, amyloid aggregates should not 
form at monomer concentrations below their fibril solubility. NP includes two variants: secondary 
mechanisms for generating fibrils either via fragmentation (NP-F) or via secondary nucleation on 
fibril surfaces (NP-SP) [Cohen et al., 2012]. NCC, in turn, presumes that fibril formation involves 
spontaneous formation of fibril intermediates (i.e. small globular oligomers). These intermediates, 
though, undergo a nucleated conversion/restructuring into rigid filaments. While NP in particular 
has been successful in modeling nucleated fibril growth from monomers, it does not provide a 
suitable description for fibril assembly along the oligomeric pathway. In contrast to NP, NCC 
requires oligomeric intermediates as precursors of fibril growth.  However, no explicit numerical or 
analytical solutions have been developed for this model.  The templated assembly (TA) model 
proposed by Griffith (1967) was conceived as model for prion-like fibril assembly. It suggests that 
spontaneous polymerization of proteins does not proceed spontaneously but requires the presence of 
a fibril template. This template is thermodynamically more stable than the monomeric state but is 
typically kinetically inaccessible [Prusiner, 1991].  In this scenario, a critical step is the initiation of 
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the template which then can catalyze the refolding of native monomers to a thermodynamically 
more stable conformation. In the TA model, the propagating template conformation is different 
from the native state [Griffith, 1967]. In addition, TA growth rates are reaction-limited by the 
number of templates added to the system. 
1.7. Amyloid Formation and the Prion Concept 
Prion diseases represent an important class of amyloid diseases. Prion diseases are 
characterized by the well-known capacity of their amyloid aggregates to induce autocatalytic self-
replication of the native protein counterpart in their host and the ability to spread this amyloid 
conformation like infectious viruses and bacteria both within a given host and transmit it between 
different hosts.  Prion (PrP) protein exists in two conformations: the normal cellular protein, termed 
PrPC, present in healthy individuals and the pathological isoform, named PrPSc after scarpie-
associated PrP [Prusiner et al., 1998; Basler et al., 1986].  Prusiner and coworkers have isolated this 
protein conformation, identified it as the disease-causing agent (PrPSc), and proposed it as the 
infectious agent in Scarpie, the prototype of prion diseases in sheep. There are no sequence 
differences between PrPC and PrPSc. Their distinction arises at the level of their structural 
organization, with PrPC being the natively folded, monomeric state while PrPSc is believed to be 
aggregated, and with a different structural organization [Pan et al., 1993;	  Stahl et al., 1993]. There is 
increasing evidence that the infective PrP species are small oligomers. In the case of transmissible 
spongiform encephalopathies (TSE), the native monomeric PrPC is converted to an abnormal 
oligomeric and/or amyloid fibril form [Prusiner et al., 1983; Silveira et al., 2005; Silm et al., 2009]. 
Detailed biophysical characterization of above-mentioned aggregates has been impeded due to 
metastable nature of these aggregates [Silveira et al., 2005]. However, there is evidence that PrPSc 
forms β-sheet rich structures, similar to other amyloid-like fibrils [Tycko & Wickenr, 2013].  While 
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there are multiple variants, the growth of prions follows a self-replication process in which PrPSc 
acts as an autocatalytic converter restructuring PrPC monomers into PrPSc β-sheet polymers. Equally 
important, a secondary process (fragmentation, surface-mediated nucleation) leads to an 
exponential replication of the prion growth units [Jarret et al., 1993; Soto et al., 2006; Caughey et 
al., 2009].  
In contrast to prion self-replication, amyloid fibril formation was believed to be entirely 
autonomous from cell to cell, tissue to tissue, and individual to individual, with no sign of 
transmissibility. These	  presumptions about the autonomous activity of various amyloid aggregates 
in cells/tissues were mostly based on in vitro assays of amyloid assembly performed under the 
partially denaturing conditions required to initiate fibril growth [Uversky et al., 2006, Uversky et 
al., 2004]. There is increasing evidence now that many amyloid diseases are in one way or another 
“transmissible” in a prion-like manner. Animal models indicate that protein amyloid aggregates 
associated with Parkinson’s, Alzheimer’s, and Huntington’s diseases spread from affected to 
unaffected areas of the tissue via prion‑like cellular transmission [Jucker & Walker, 2013; Masuda-
Suzukake et al., 2013; Clavaguera et al., 2009; Pecho-Vrieseling et al., 2014]. More specifically, 
experiments with animal models and in vitro assays have suggested that oligomers underlie the 
spread of both prion and Alzheimer’s disease in vivo [Jucker and Walker 2011, Silveira et al., 2005; 
Prusiner et al., 2012]. Whether and how various amyloid aggregates, once formed, interact with 
their native counterparts under physiological conditions is not understood.  
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Chapter 2 
Outline of Dissertation Work 
The broader goal of my research in Dr. Muschol’s laboratory is to unravel basic molecular 
mechanisms that regulate the nucleation and growth of amyloid proteins into amyloid fibrils under 
various environmental conditions. This objective is important since the mechanisms that result in 
the formation of amyloid fibrils in vitro under both denaturing and physiological conditions are still 
poorly understood. 
One project I contributed to was the identification of reliable indicators for the formation of 
amyloid fibrils along distinct assembly pathways. In vitro studies from multiple laboratories had 
suggested that self-assembly of amyloid fibrils may proceed via at least two distinct assembly 
pathways, involving either transient formation of amyloid oligomers and their curvilinear polymers 
or direct nucleation of late-stage rigid filaments from partially unfolded monomers. Given the 
presumed role of oligomer intermediates as the major toxic species in amyloid diseases, 
understanding what mechanisms/conditions promote or suppress the formation of such oligomeric 
intermediates is of critical importance. The transient nature of intermediate oligomer limits the 
biophysical and biochemical approaches for investigating and fully characterizing these amyloid 
species. These experimental challenges can be compensated by combining a broad range of 
biophysical approaches to determine kinetic, morphological, tinctorial, and structural characteristics 
of fibril assembly along the oligomeric vs. the filamentous assembly pathway.  Specifically, we 
followed the structural evolution of the monomers along either assembly paths from their native 
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conformation to their amyloid end state.  Experiments were performed using the model amyloid hen 
egg-white lysozyme. Transitions in assembly behavior were induced by changes in salt-
concentration. As experimental read-outs of kinetics we used static and dynamic light scattering 
(SLS and DLS) as well as thioflavin T (ThT) fluorescence spectroscopy.  Aggregate morphologies 
were determined using atomic force microscopy (AFM). Structural characteristics were determined 
using Fourier transform infrared spectroscopy (FTIR) and aggregate- specific enhancements in ThT 
fluorescence emission. Details of these experiments and their results are presented in part I of the 
dissertation (Chapter 3). 
The main focus of my doctoral research, though, was on the mechanisms of in vitro amyloid 
formation near physiological solution conditions. Typically, in vitro growth of amyloid proteins 
requires the use of partially denaturing solution conditions.  This has raised concerns whether the 
mechanisms of amyloid formation under in vitro growth conditions are relevant to the process of 
amyloid formation under near physiological conditions. I investigated the hypothesis that amyloid 
formation under physiological conditions would indeed be a “two-phase” process that resembled 
prion-like behavior. We used an initial “induction” step under partially denaturating conditions to 
permit the spontaneous formation of amyloid aggregates. This step was intended to mimic the 
process of spontaneous prion formation in vivo. Amyloid aggregates generated during the induction 
step were then isolated and tested for their stability under physiological conditions. In a subsequent 
“proliferation step”, these amyloid seeds were then tested for their capacity to undergo prion-like 
self-replication from their native counterparts in vitro and under near physiological conditions. 
These experiments were performed on all three distinct amyloid aggregate species: aOs, CFs, and 
RFs. Part II of the dissertation, describes my experiments to test our hypothesis of “prion-like 
 
 
15	  
	  
 
amyloid propagation” using three distinct amyloid proteins: lysozyme (chapter 4), transthyretin 
(chapter 5) and β2-microglobulin (chapter 6). 
Part III of the dissertation summarized experiments on the self-assembly of poly glutamic 
acid (PLE) into amyloid spherulites. We originally intended to study PLE amyloid assembly to 
explore the effects of polydispersity on amyloid self-assembly. However, we noticed that PLE from 
two different sources resulted either in the formation of thick, frayed bundles of amyloid fibrils or 
in the formation of highly ordered amyloid spherulites. As described in chapter 7, we provided 
evidence that  these two distinct amyloid morphologies were tightly correlated to differences in the 
conformations of the PLE monomers. The ability of PLE to grow into macroscopic aggregates with 
distinct geometries and multiple length scales may make the PLE a possible candidate for 
biomedical application. 
Finally, appendix I provides a brief overview of the experimental techniques used in my 
dissertation work, including SLS and DLS, nano particle tracking analyses (NTA), AFM, 
transmission electron microscopy (TEM), FTIR and circular dichroism (CD) as two key 
experimental approaches for determination of the secondary structure, and fluorescence 
spectroscopy with ThT fluorescence and intrinsic tryptophan fluorescence.  
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Part I : Self-Assembly of Lysozyme along Distinct Assembly Pathways 
 
Chapter 3 
Structural Evolution during Oligomeric vs. Oligomer-free Amyloid Fibril Growth 
 
 
3.1. Introduction 
 Amyloid deposits formed by disease-specific proteins are the molecular hallmark of diverse 
human disorders including Alzheimer’s disease, type II diabetes, or prion disease. While the various 
proteins or proteolytic fragments that form amyloid fibrils in different diseases have no structural or 
functional similarities, the resulting amyloid aggregates share basic characteristics. The specific 
amyloid-related characteristics include the prominent cross β-sheet structure of the fibrils. There is 
increasing evidence that amyloid formation tends to proceeds along one of two separate assembly 
pathways resulting in either rigid filaments or globular oligomers and curvilinear fibrils [Gosal et 
al., 2005; Hill et al., 2009;  Kodali et al., 2007; Yong et al., 2002; Vitalis et al., 2012; Foley et al., 
2013; Miti et al., 2015]. While the rigid filaments pathway involves the nucleation and cross-
assembly of long-straight fibrils (oligomeric-free pathway), the oligomeric pathway produces 
globular oligomers, which later on self-assemble into curvilinear polymers. Recent findings 
persistently implicate oligomeric intermediates as the most toxic entity [Campioni et al., 2010; 
Kayed et al., 2004; Ono et al., 2009; Klein et al., 2001; Cleary et al., 2005]. Given the focus on 
oligomers as major toxic species, the very existence of an oligomer-free assembly pathway is 
significant. Little is known, though, about the structure of the various intermediates emerging along 
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different pathways and whether the pathways converge towards a common or distinct fibril 
structures. The transient and short-lived nature of these intermediates presents some limitations on 
characterizing their biophysical properties. A quantitative characterization of the  growth kinetics, 
morphologies and structure of different amyloid intermediates represents an important progress 
toward unraveling the relationship between different types of intermediates and their role in 
amyloid fibril formation, and it is critical step for unraveling the causes of cell death associated 
with amyloidoses.  
 Previous findings from our lab have reported that depending on the growth conditions, 
lysozyme can self-assemble at least into two different pathways: rigid (monomeric) fibril assembly,  
and oligomeric/protofibril (often known as curvilinear fibrils) assembly [Hill et al., 2011].  We 
further probed the structural and morphological evolution as well as the growth kinetics of 
intermediates and late-stage aggregates formed during in vitro lysozyme’s self-assembly along the 
oligomeric and oligomeric-free pathway. In this study, we utilized a combination of FTIR, the 
amyloid-specific fluorescent ThT, DLS/SLS and AFM to investigate the amyloid self-assembly via 
distinct pathways. Initially, we determined the morphology and growth kinetics of aggregates 
formed along these two distinct assembly pathways of lysozyme in vitro. We specifically examined 
whether ThT fluorescence responses contained ancillary information about the structure and 
structural evolution of amyloidogenic intermediates. In addition, the ThT fluorescence signature 
obtained during oligomeric growth kinetics is compared/contrasted to those of oligomeric-free 
pathway. Furthermore, we investigated the structural evolution of these aggregates as documented 
by FTIR data. In order to gain additional information about the structure of amyloid intermediates, 
the FTIR and ThT measurements were correlated against each other. As a result, we were able to 
make specific statements regarding the structural fingerprints and the evolution of lysozyme’s 
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aggregates emerging during oligomer and oligomer-free amyloid fibril growth.  Part of this work 
was published in the Journal of Chem. Phys. 139, 121901 in 2013. 
3.2. Results and Discussion 
 3.2.a.  Morphological Features of Lysozyme Amyloid Aggregates  
  Depending on ionic strength amyloid assembly of lysozyme at fixed protein concentration 
and pH 2 follows either an oligomeric-free filamentous or oligomeric assembly pathways [Hill et 
al., 2011]. At low ionic strength (<150mM), fibril formation proceeds in the absence of any 
oligomers (Figure 3.1a). The cross-section area of fibrils grown under low ionic strength 
corresponds to that of lysozyme monomers [Hill et al., 2011].  
	  
	  	  	  	  	  	             	  	  	  	  	  	   	  
 
Figure 3.1. Morphologies of Lysozyme Aggregates Grown at Low pH. AFM images of (a) Rigid fibrils 
showing two distinct populations: rigid filaments (orange) and bundled fibrils (green), grown at (50 mM 
NaCl at pH = 2 and T = 50 0C) solution;  (b) Early-stage oligomers (orange/green)  grown at (175 mM NaCl 
at pH=2 and T=50 0C) solution; or (c) late-stage protofibrils also grown at (175 mM NaCl at pH =2 and 
T=50 0C) solution. Notice, protofibrils display a much more curvilinear geometry and are noticeably thicker 
compare to rigid filaments. The scale bar in AFM images represents 1µm in  panel(a) and 250 nm in panels 
(b) &(c). False color height scales are identical in all images. 
 
This pathway is characterized by a long lag period, often lasting days before a prominent nucleation 
event occurs, resulting in the formation of monomeric filamentous of two distinct average lengths. 
Increasing the ionic strength (>150 mM) results in a sharp pathway switches: from monomeric 
  (a)                                                  (b)                                           (c) 
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filamentous to oligomeric fibril growth. The oligomeric pathway is associated with a steady rate of 
oligomer formation followed by nucleation of oligomeric polymers (Figure 3.1b & 3.1c). The 
oligomers themselves are composed of about eight monomers [Hill et al., 2009]. While rigid 
filaments are very straight and mechanically stiff, oligomeric filaments develop highly curvilinear 
geometries and we will refer to them as curvilinear fibrils (CFs) (Figure 3.1c). To summarize, while 
the building blocks of filaments are monomers, the building blocks for CFs are oligomers. 
 
3.2.b. Characterization of Growth Kinetics along Distinct Pathways of Lysozyme Aggregation 
  ThT fluorescence is	  broadly considered as a universal indicator of amyloid fibril formation 
due to its significant increase in fluorescence emission upon binding to amyloid fibrils. ThT binds 
to diverse protein fibrils, despite their distinct amino acid sequences, suggesting that ThT 
recognizes a structural feature common among fibrils. Because amyloid fibrils share the cross-β 
sheet architecture, it is generally accepted that the surfaces of amyloid fibrils form the ThT-binding 
sites [Biancalana et al., 2010]. Previous study shows that the time course of ThT fluorescence 
responses is different along the oligomer-free vs oligomer assembly pathway [Smith et al., 2003]. 
Using ThT fluorescence, we had two goals: first, whether ThT displays difference in its intrinsic 
sensitivity to different intermediates within a given pathway, and second, to determine whether ThT 
fluorescence shows difference across the two different pathways of lysozyme. Possible differences 
in ThT emission intensity for specific aggregates, in turn would hint at differences in aggregates 
structure. In addition, such differences could help detect any evolution in aggregate structures as it 
changes from the native to the amyloid state along either one of the two assembly pathways. 
Specific pathway signature in ThT responses were correlated against aggregation-induced changes 
in SLS and DLS. Figure 3.2.a shows the changes in ThT fluorescence emission intensity (solid red 
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squares) for oligomer-free filaments growth obtained from offline measurements, where ΔF/F0 
represents the relative increase in fluorescence over the same lysozyme/ThT solution prior to 
incubation. The rapid enhancement in the ThT fluorescence ratio ΔF/F0 corresponds with the 
nucleation of filaments in the sample.  
 
         
               
Figure 3.2. ThT Fluorescence and Light Scattering Intensity Display Pathway-specific Signatures 
during Lysozyme Assembly. Fractional changes in ThT fluorescence intensity (red filled squares) and light 
scattering intensity (open blue squares) measured for lysozyme undergoing oligomer-free filament growth 
(50 mM NaCl, pH 2, 50 0C) (a); or oligomeric growth (175 mM NaCl, pH 2 and 50 oC) (c). The sudden 
increase in signals in (a) coincides with the nucleation of rigid filaments seen in DLS as is shown above. In 
the oligomeric-free pathway, during an extended lag period a single peak with monomeric radius of 
lysozyme (Rh = 1.9 nm) persists until two additional peaks emerge with maximal radii near 400 nm and 40 
nm, respectively as indicated by particle size distribution obtained from DLS (b). (c) In the oligomeric 
pathway, signals enhance continuously implying formation of oligomers prior to nucleation of CFs from 
oligomers. (d) The subtle upward drift in the monomer peak results from the formation of small populations 
of oligomers readily seen in AFM. The new peak emerging around 15 h indicates the nucleation of 
curvilinear fibrils (CFs) formed from oligomers. 
 
 (a)                                                              (b) 
 (c)                                                               (d) 
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Nucleation of the filaments is also confirmed by the increase in light scattering intensity (open blue 
squares in Figure 3.2a)  and the appearance of a new aggregate population in DLS with 
hydrodynamic radius near 400 and 40 nm respectively (Figure 3.2b). This nucleation event 
coincides with the appearance of rigid filaments in AFM images with lengths distributions 
consistent with the two DLS peaks. In this pathway, fractional increases in ThT fluorescence are 
dramatic (over 90-fold within 120 hours of incubation period). Superimposed with the ThT 
fluorescence ratios are the corresponding fractional changes in the light scattering intensity 
(ΔIscat/I0) from the same sample. In this pathway, the fractional changes in scattering intensity over 
the entire incubation period are quite modest (≤2.5-fold). Neither scattered light nor ThT 
fluorescence signal enhances before the nucleation event occurs (Figure 3.2a & 3.2b). While the 
fractional amplitude changes of these two signals (light scattering and ThT fluorescence) are very 
different, the superposition of the two signals (Figure 3.2a) reveals that their respective time courses 
are directly correlated, as expected. The same set of measurements for lysozyme undergoing under 
oligomeric assembly are presented in Figures 3.2.c and 3.2.d respectively. In the oligomeric 
pathway, ThT fluorescence increases continuously, but enhancement accelerates significantly 
throughout incubation period. The overall enhancement of ThT signal in the oligomeric pathway is 
about 12 fold compared to the background fluorescence. As in the oligomer-free pathway, the time 
course for the fractional increases in scattered light and ThT fluorescence are identical. In stark 
contrast to the oligomeric-free pathway, both ThT fluorescence and scattered light intensity increase 
continuously even before the nucleation of curvilinear fibrils (CFs) occurs, implying the formation 
of oligomers prior to CFs nucleation. Moreover, the fractional increases in ThT fluorescence signal 
and scattering intensity under oligomeric growth conditions are of comparable magnitude. These 
data suggest that differences in both relative amplitude and time course of ThT fluorescence signals 
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are diagnostic of the specific fibril assembly pathway they occurred in. More importantly, matches 
of fractional enhancements in scattered light and ThT fluorescence in oligomeric pathway indicates 
the formation of intermediate population along this pathway. In contrast, lack of enhancement in 
either ThT signal and/or scattered light during oligomeric-free assembly before the nucleation of 
filaments occurs, suggests lack of any intermediate amyloid oligomers.  
 The observed correlation between ThT fluorescence and scattering intensity enhancements 
in oligomeric pathway is surprising. While the enhancement in ThT emission intensity is 
proportional to the total amounts of “amyloidogenic” material, scattering intensity is heavily 
weighted towards aggregates with higher molecular weight. To a first order of approximation, light 
scattering is proportional to the square of the aggregates’ molecular weight. The reported 
enhancement in ThT fluorescence and scattered intensity suggests that the ThT fluorescence 
response and scattering intensity are dominated by changes in the number of aggregates in solution. 
The temporal evolution of the particle size distribution derived from DLS supports that 
interpretation by showing little change in aggregate sizes during the incubation period (Figure 3.3). 
In the oligomeric pathway, after the nucleation of the curvilinear fibrils from oligomers the average 
hydrodynamic radii changed very little (Figure 3.3a). At the same time, the scattered intensity 
continued to enhance dramatically. No discernible changes in hydrodynamic radii after the 
nucleation event were observed in the oligomeric-free pathway, as well. Increases in the number of 
aggregates in the absence of size’s growth could possibly be related to either fibril fragmentation 
and/or secondary nucleation. The mechanism of fragmentation has been experimentally observed in 
other proteins [Masel et al., 1999; Tanaka et al., 2006; Knowles et al., 2009]. Further investigation 
of this correlation between ThT and SLS responses, and the modest increase in hydrodynamic radii 
are described in more details in chapter 5 of this dissertation.   
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Figure 3. 3. Temporal Evolution of Aggregate Peaks along Different Pathways of Lysozyme Growth. 
Particle size distributions (PSDs) derived from DLS measurements for either (a) oligomeric fibril assembly 
(pH=2; 175 mM NaCl) or (b) oligomer-free filamentous growth (pH = 2; 50mM NaCl). The gray bars 
indicates the PSD obtained shortly after (a) nucleation of curvilinear fibrils (CFs) or (b) nucleation of the 
two populations of rigid filaments (short and long filaments). The empty bars, in turn, represent the 
corresponding PSDs after (a) 35 hrs or (b) 118 hrs of incubation period.  
Furthermore, we wanted to test whether pathway-specific ThT responses were independent 
of the growth conditions and represent a “generic scenario”. However, the above-mentioned 
experiments were performed in acidic pH solutions. We were aware of noticeable protein 
hydrolysis at highly acidic pH. For that purpose, we extended our study to pH 7, where hydrolysis 
is noticeably reduced [Mishra et al., 2007]. More importantly, pH 7 solutions are close to 
physiological/biomedical conditions. At pH 7 though, we could only generate amyloid oligomers 
and curvilinear fibrils (Figure 3.4a). Figure 3.4b shows growth kinetics of lysozyme undergoing 
oligomer/CFs assembly at pH 7, highlighting a continues growth indicated by both ThT 
fluorescence and scattering intensity enhancements. Similar to the pH 2 oligomeric pathway, at pH 
7 enhancement of ThT fluorescence and light scattering followed the same time course, and the 
magnitude of enhancement of ThT fluorescence and scattered light were equal (for 5 hours of 
incubation period both ThT fluorescence and scattered intensity increases ~ 2.5 fold).  The specific 
     (a)                                                                  (b) 
CFs 
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signature in light scattering, ThT fluorescence and AFM images of aggregates formed at pH 7 
indicated that amyloid formation followed the oligomeric assembly pathway. These experiments 
(Figure 3.2-3.4) suggests that there is a pathway-specific difference in ThT and DLS/SLS 
responses, independent of the growth conditions, of protein hydrolysis, and this difference persisted 
near physiological growth conditions of pH 7. 
 
Figure 3.4. Assembly of Lysozyme Amyloids at Physiological pH via the Oligomeric Pathway. (a) AFM 
image of oligomers and early state protofibrils grown at pH 7 (40 mM NaCl, T=70 oC). Correlation of ThT 
fluorescence (■) and light scattering (ο) ratios in oligomeric pathway at pH 7 (b). Panel (b) indicates that 
specific pathway ThT and light scattering signatures were independent of the growth conditions, of protein 
hydrolysis, and persisted near physiological growth conditions of pH 7  (pH 7, 40 mM NaCl, T = 70 oC). 
 
3.2.c. Evolution of Secondary Structure of Intermediates along the Oligomer-free vs. Oligomeric  
Assembly Pathways 
To test if there are any differences in the secondary structure between amyloid aggregates 
generated during the oligomer-free vs. oliogomeric assembly pathways we performed Attenuated 
Total Reflectance Fourier-Transform infrared spectroscopy (ATR-FTIR) measurements. Figure 
3.5a shows the Amide I peak of the FTIR spectra of native Lysozyme, dominated mostly by its α- 
helix peak at 1655 cm-1.  The corresponding spectra for late state rigid fibrils grown under low ionic 
    (a)                                                                                 (b) 
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strength conditions solution (50 mM NaCl) and late state CFs grown in the presence of 175 mM 
NaCl are shown in Figures 3.5b and 3.5c respectively. Aggregated samples were subjected to 
ultracentrifugation and the resulting pellets were re-suspended prior to FTIR measurements. Figure 
3.5 (b&c) displays a prominent β-sheet peak around 1620 cm-1 for both oligomer-free and 
oligomeric fibril assembly, indicating that both pathways generate a β-sheet structure. The 1620 cm-
1 β-sheet peak is considered diagnostic of amyloid assembly [Zandomeneghi et al., 2004]. Figures 
3.5b and 3.5c also retain a significant contribution from the α-helix peak (1655 cm-1) for both 
oligomeric and oligomeric-free pathway spectra. This implies that lysozyme fibrils preserved 
secondary structure components from the lysozyme’s native state. This observation is consistent 
with NMR structure determination for lysozyme fibrils grown under equivalent growth conditions 
[Frare et al., 2004]. For a given sample, the raw FTIR spectra (solid lines) were decomposed into 
individual Gaussian peaks (dotted lines) by fitting then Amide I and Amide II peaks. Peak positions 
in the amide I band of the spectra were identified using the Fourier Self-deconvolution (FSD), and 
second derivative algorithms within the OPUS software analysis package. Gaussian curves were 
fitted from 1550 cm-1 to 1700 cm-1. As  is shown in Figures 3.5 (b&c) the relative peak area of  the 
amyloid β-sheet peak (~1620 cm-1) significantly increased at the expense of α-helix content (1655 
cm-1) for both oligomer-free and oligomeric growth. These features are already apparent in the raw 
spectra. Closer inspection of Figures 3.5 (b&c) reveals that the β-sheet peak of fibrils grown in the 
oligomer-free pathway appeared at a higher wavenumber when compared to the corresponding peak 
for the oligomeric pathway, indicating a subtle structural difference between  amyloids grown under 
oligomeric growth conditions vs. those grown under oligomeric-free growth conditions. 
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Figure 3.5. Amide I peak of  Native Lysozyme and Amyloid Aggregates grown at pH 2.0. (a) Amide I 
peak of Native Lysozyme vs. amyloid aggregates analyzed after incubation and ultracentrifugation under (b) 
oligomer-free or (c) oligomer growth conditions.	  Black solid lines represent the raw spectra while black 
dotted lines indicate the Gaussian decomposition of the spectra into α-helix, β-turn, and β-sheet peaks as well 
as the resulting overall fit to the raw spectra. The bar graphs to the right of each spectrum represent the 
relative amplitudes of the α-helix and β-sheet peaks derived from spectral decomposition. 
 
 
The difference spectra in Figure 3.6 represent subtraction of native lysozyme spectra from 
respective aggregates’ spectra for oligomeric protofibrils (red dotted curve) and rigid filaments 
(black solid curve) (see materials and methods for more details). These spectra highlight the spectra 
differences in amyloid β-sheet peaks between amyloid assemblies grown under oligomeric-free or 
oligomeric growth conditions. While the oligomer-free assembly induced an amyloid β-sheet peak 
at 1623 cm-1 , the oligomeric assembly developed an amyloid β-sheet peak at 1618 cm-1. In 
(a) 
(b) 
(c) 
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addition, the difference spectra document the concurrent loss in α-helix content. We explored 
whether lysozyme aggregates generated near physiological pH values share structural features to 
those grown at low acidic pH. As we showed in section 3.2.b, at pH 7 we were able to grow only 
oligomers and CFs (Figure 3.4).  
  
Figure 3.6. FTIR Difference Spectra of the Amide I Region for Oligomer-free vs. Oligomeric 
Assembly. The spectra represents subtraction of native lysozyme spectra from respective aggregates’ spectra 
for oligomeric curvilinear fibrils (CFs) grown at pH 2, 175 mM NaCl and 50oC (red dotted curve), 
oligomeric CFs grown at pH 7, 20 mM NaCl and 65oC (blue dotted curve) or rigid filaments grown at pH 2, 
50 mM NaCl and 50oC (black solid curve). Differences in prominent β-sheet structures between oligomer 
(1618 cm -1) and oligomeric free (1623 cm-1) assembly pathway are highlighted in this display. Oligomers 
and CFs grown at either pH 2 or pH 7 display almost identical spectra.   
 
In Figure 3.6 superimposed with difference in spectra of curvilinear fibrils grown at pH 2 are the 
FTIR difference spectra for CFs grown at pH 7 and 20 mM NaCl. The FTIR difference spectra 
shows that curvilinear fibrils grown near physiological pH values share identical structural features 
with those grown at pH 2. We, therefore, conclude that pathway- specific structural differences are 
characteristics of specific fibril assembly pathways. It may be worth recalling that these structural 
differences are correlated to their differences in ThT responses and their morphologies (Figure 3.1; 
3.2a,c; & 3.4b).   
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3.2.d. Structural Evolution along the Oligomeric Fibril Assembly Pathway 
The above data (Figure 3.2c,d & 3.4b) showed that oligomeric intermediates form without 
any lag period with CFs nucleation occurring after several hours of incubation period. While late 
stage of CFs display a characteristic β-sheet structure (Figure 3.6c), it remained unclear at what 
stage of the assembly process the characteristic β-sheet structure emerges. For that purpose, we 
followed the structural evolution along the oligomeric assembly pathway using ATR-FTIR. The 
“lag period” and CFs nucleation was monitored using DLS. The FTIR spectra of the samples were 
collected at different time points during the fibril assembly. To avoid monomeric contribution to the 
FTIR spectra, FTIR difference spectra between native monomeric background and incubated 
sample were determined. Figure 3.7 shows the resulting difference in Amide I spectra at different 
points during incubation of a lysozyme sample undergoing oligomeric fibril growth. The amyloid 
specific β-sheet peak around 1618 cm-1 and a loss of α-helix content emerged even during the “lag 
phase” dominated by oligomers.  
     
Figure 3.7. Temporal Evolution of the Amide I Difference Spectra for Lysozyme undergoing 
Oligomeric Fibril Growth. The amyloid specific β-sheet peak around 1620 cm-1 ,and a loss of α-helix 
content emerged even during the “lag phase” dominated by oligomers. 
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As incubation period progressed, the amplitude of these two features of the difference 
spectra increased in amplitude. However, no change in amyloid β-sheet peak position (~1620 cm-1) 
was observed as incubation progressed. A structural evolution during aggregation  is also observed 
in the region 1700-1680 cm-1. This 1700-1680 cm-1 peak was also	  observed for other systems, and it 
was attributed to antiparallel β-sheet structures [Cerf, Sarroukh, Tamaizu-Kato, Breydo, et al., 
2009]. We did not systematically explore this feature due to the intrinsic noise limitations in our 
data.  
3.3. Summary  
 One of the goals of our study was to explore whether these two pathways represent two 
distinct and competing pathways or whether the oligomeric pathway is just “on” pathway for rigid 
fibril formation.	  The AFM images display distinct morphological properties of aggregates. We 
documented that late state aggregates, generated in either pathway display significant responses in 
thioflavin T fluorescence of distinct amplitudes. ThT fluorescence enhancement during early stage 
of incubation i.e. prior to curvilinear fibrils nucleation is due to spontaneous oligomer formation. 
On the other hand, lack of ThT fluorescence and scattered light enhancement prior to the nucleation 
event during oligomeric-free pathway suggests the lack of any intermediate entity along this 
pathway. FTIR spectra of late-stage lysozyme aggregates formed along either of these two 
pathways display a dominant β-sheet peak around 1620 cm-1. The 1620 cm-1 peak is broadly 
considered diagnostic of amyloid β-sheet structures [Zandomeneghi et al. 2004]. Noticable β-sheet 
peaks observed prior to CFs nucleation during oligomeric growth indicate that structural 
rearrangement of early stage oligomers matches those of late-stage CFs. These results suggest that 
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aggregates formed along either pathway are “amyloidogenic” in nature. At the same time, FTIR and 
ThT data point to the pathway-specific structural differences.  
The ThT response amplitudes were readily distinguishable between the two pathways. This  
feature implies that ThT recognized distinct structural conformations of intermediates of mature 
fibrils formed either along the oligomeric-free vs. the oligomeric pathway. Our data suggests that 
FTIR spectra and   ThT responses were unaffected by changes the extend of lysozyme hydrolysis, 
or solution pH. Therefore, fibril formation produces structural fingerprints that is specific to the 
pathway along which the fibrils have grown. These fingerprints can be cross-examined with either 
FTIR spectroscopy or ThT fluorescence. The pathway-specific response in both FTIR spectra and 
ThT fluorescence opens the possibility that either FTIR or ThT measurements can be utilized as a 
tool to resolve which pathway fibril formation follows in vivo. The prominent amyloid β-sheet for 
the oligomeric-free pathway is observed at ~1623 cm-1 vs. at ~1618 cm-1 in the oligomeric pathway. 
Additional peak in the range 1700-1680 cm-1 is seen for aggregates grown along the oligomeric 
pathway. This peak (1700-1680 cm-1) is consistent with spectra for antiparallel β-barrel proteins 
[Cerf, Sarroukh, Tamaizu-Kato, Breydo, et al. 2009]. The pathway-specific difference in FTIR 
spectra were highly reproducible and independent of growth conditions. Moreover, the oligomeric 
aggregates generated at physiological pH solution showed the same FTIR spectra as those grown in 
highly acidic pH solutions. We therefore conclude that hydrolysis does not affect the structural 
features observed either in FTIR or ThT emission spectra.  
Combination of FTIR spectroscopy and intrinsic ThT fluorescence responses permitted 
monitoring the temporal evolution of intermediate structures along a given amyloid fibril pathway. 
For the oligomer-free pathway, these intermediates include short and long rigid filaments and 
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bundled filaments, which cross-assembled from rigid filaments. For the oligomeric assembly 
pathway, the range of intermediates includes oligomers and CFs. Our findings suggest that the 
dominant pathway-specific structural features recognized by ThT and FTIR are established by the 
earliest intermediates emerging in either pathway and remain preserved through subsequent 
generations of amyloidogenic intermediates. This implies that the main structural transition from a 
near native to an amyloidogenic state occurred within a single step. This step takes place either 
right before or as a result of the very first aggregation event (i.e., nucleation of rigid filaments or 
formation of compact oligomeric intermediates). The above results are consistent with reports that 
partially denatured proteins can develop extended β-sheet conformations even prior to the onset of 
aggregation [Yang et al., 2003]. The first atomic resolution structure for oligomers grown from a 
segment of αB crystalline is also consistent with the above-mentioned observations [Laganowsky et 
al., 2012]. Laganowsky and coworkers showed that amyloid-related oligomers have an antiparallel 
β-barrel structure of cylindrical shape (see Figure 2.3 in background section). These oligomers X-
ray diffraction patterns are compatible with the cross-β sheet structures of mature amyloid fibrils. 
Therefore, normalized ThT responses and FTIR spectroscopy offer an appealing way to follow the 
structural evolution of amyloid fibril formation and represent a unique opportunity to determine 
which pathway amyloid formation follows in vivo. 
3.4. Materials and Methods 
3.4.a. Protein and Chemicals 
Two times recrystallized, dialyzed, and lyophilized hen egg white lysozyme (HEWL) was 
purchased from Worthington Biochemicals (Lakewood NJ) and was used for all experiments. 
Ultrapure grade thioflavin T was obtained from Anaspec (Freemont, CA).  All other chemicals were 
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purchased from Fisher Scientific (Pittsburgh, PA) and were reagent grade or better. All solutions 
were prepared using 18 MΩ water from a reverse osmosis unit (Barnstead E-pure, Dubuque, IA). 
3.4.b.  Preparation of Lysozyme Growth Solutions and ThT Solutions  
Lysozyme was dissolved at twice its final concentration in either 25 mM KH2PO4 at pH 2 or 20 
mM HEPES at pH 7 buffer and was briefly placed in a water bath at 45 oC to help dissolve 
preformed clusters. Samples were consecutively filtered through 220-nm and 50-nm pore size 
syringe filters. This concentrated HEWL stock was mixed 1:1 either  with a NaCl /25 mM KH2PO4 
pH 2 or with a NaCl /20 mM HEPES pH 7 stock solutions, with NaCl concentrations in this 
salt/buffer stock adjusted to twice their final concentrations. Actual lysozyme concentrations were 
determined from UV absorption measurements at 280 nm (a280 = 2.64 ml mg−1 cm−1). These 
solutions were placed in standard glass cuvettes (Starna Cell, Atascadero, CA) and were incubated 
at 50 oC (pH 2) or 65 oC (pH 7) for as little as 4 h and as long as 5 days using a dry bath or the 
thermostated cuvette holder of a dynamic light scattering unit (Zetasizer S, Malvern Instruments, 
Worcestershire, UK). For accelerated growth of rigid fibrils at pH 2, fibril seeds were grown at pH 
2 in 100 mM NaCl for 2.5 days. A freshly prepared lysozyme solution was then mixed with 3% of 
the seeding solution and was incubated for 24 h under the same growth conditions. Accelerated 
growth of oligomeric samples within just hours, in turn, was achieved by raising NaCl 
concentrations to 325 mM. ThT stock solutions were prepared by dissolving 1 mM dye in distilled 
water and passing them through 220-nm syringe filters. Actual ThT concentrations were determined 
from absorption at 416 nm (α416 = 26 620 ml mg−1 cm−1). These solutions were further diluted to a 
final stock concentration of 212 µM. 
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3.4.c. Static and Dynamic Light Scattering 
 SLS and DLS measurements were performed using the back scattering geometry (θ = 173◦) of a 
Zetasizer Nano S (Malvern Instruments, Worchestershire, UK) with a 4 mWHe-Ne laser (λ = 633 
nm) and a temperature-controlled sample compartment. During in situ measurements of fibril 
growth, autocorrelation functions of scattered light were collected typically every 10-30 min, using 
acquisition times of 180 s per measurement. Autocorrelation functions were converted into particle-
size distributions (PSDs) using the “narrow modes” or “general purpose” algorithms provided with 
the Zetasizer Nano S. Changes in scattering intensity were monitored simultaneously using the 
count rates of an avalanche photodiode photon detector.  
3.4.d. FTIR Spectroscopy of Lysozyme Solutions 
ATR-FTIR spectroscopy was performed on a Bruker Optik Vertex 70 (Ettlingen, Germany) 
spectrometer with a mid-infrared source and a pyroelectric DLATGS (deuterated Lalanine doped 
triglycene sulphate) room temperature detector. Usually, 30–40 µL of protein solution was placed 
on the thermostated silicon crystal of a BioATRcell II (Harrick Scientific Products, Inc.; 
Pleasantville, New York) ATR accessory. FTIR spectra were acquired between 1000 cm−1 and 4000 
cm−1 wavenumbers. All spectra were taken at 24 oC with an aperture setting of 8 mm and a scanner 
velocity of 10 kHz. Water vapor contamination of the spectra was minimized using the atmospheric 
compensation algorithm within the OPUS software analysis package (version 6.5, Bruker Optik). 
Background spectra of the buffer solution without protein were recorded over 200–400 scans at 2 
cm−1 resolution and subtracted from the sample spectra. Typically, three such runs were averaged 
prior to data analysis. The Amide I and Amide II bands (1500–1700 cm−1) were subjected to a 
combined peak and deconvolution analysis. Peak positions in the Amide I band of the spectra were 
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identified using the Fourier Self-deconvolution (FSD) (Bandwidth 6 cm−1; Enhancement 2.4) and 
second derivative (13 smoothing points) algorithms within the OPUS software analysis package 
(version 6.5, Bruker Optik). After a horizontal baseline correction, Gaussian curves were fitted 
from 1550 cm−1 to 1700 cm−1. We accounted for the overlap of the Amide I and Amide II band by 
fitting the entire Amide I band together with the high-frequency portion of the Amide II band. Peak 
positions were fixed to the values identified by FSD, and second derivative algorithms while the 
intensity and widths of the Gaussian curves were optimized using the Levenberg-Marquardt 
Algorithm. To avoid unreasonable broadening of Gaussian peaks observed for some spectra, peak 
widths were restricted to values near those obtained with native lysozyme. For comparing spectra 
from different fibril samples (Figure 3.6), baseline corrected spectra were normalized to the integral 
over their Amide I bands. Difference spectra were obtained by subtracting the normalized reference 
spectrum of monomeric lysozyme from the spectra of the aggregated samples (Figure 3.6). These 
spectra were renormalized by dividing each by the values of their respective β-sheet peaks. For 
measurements of the temporal evolution of the FTIR difference spectra (Figure 3.7) sample aliquots 
were removed at different times (4 h, 1 day, 4 days, 7 days, 11 days) and the initial monomer FTIR 
spectrum at 25 ◦C was used for subtraction.  
3.4.e. Thioflavin T Fluorescence Spectroscopy 
ThT fluorescence measurements were performed using a FluoroMax-4 spectrofluorometer (Horiba 
Jobin Yvon, Edison, NJ). ThT fluorescence was excited at 445 nm and emission spectra were 
measured between 465 nm and 565 nm. For each ThT fluorescence measurement, small sample 
aliquots were removed from the HEWL growth solution and were mixed with the ThT stock 
solution. In order to minimize potential changes to the particle size distribution arising from 
dilution during ThT measurements, only 3.3 µl of the 212 µM ThT stock solution was added 
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directly to 66.7 µl of the undiluted lysozyme aliquots, resulting in a final ThT concentration of 10 
µM. ThT/HEWL mixtures were transferred into small volume quartz cuvettes and allowed to 
equilibrate for 5 min before recording ThT fluorescence emission. For each data point, at least two 
separate ThT/HEWL solutions were prepared and their fluorescence analyzed. Offline ThT 
fluorescence measurements were taken at regular intervals (typ. 2-6 times/day) while light 
scattering was monitored in situ as described above. Correlated DLS/SLS and ThT measurements 
ceased when light scattering indicated the onset of sample gelation. All ThT measurements were 
taken at room temperature. Using DLS we confirmed that the addition of ThT, the minimal dilution 
of the samples for ThT measurements, or the lower temperature used during fluorescence 
measurements did not noticeably alter the size distribution of HEWL aggregates. 
3.4.f. Atomic Force Microscopy (AFM)  
Amyloid fibrils were imaged in air with a MFP-3D AFM (Asylum Research, Santa Barbara, CA) 
using NSC36/NoAl (Mikromasch, San Jose, CA) or PFP-FMR-50 (Nanosensor, Neuchatel, 
Switzerland) silicon tips with nominal tip radii of 10 nm and 7 nm, respectively. The cantilever was 
driven at 60–70 kHz in alternating current mode and at a scan rate of 0.5 Hz, acquiring images at 
512 × 512 pixel resolution. Raw image data were corrected for image bow and slope. For imaging, 
75 µl of fibril solution was diluted 20 to 100-fold into the same salt/buffer combination used during 
growth, deposited onto freshly cleaved mica for 3–5 min, rinsed with deionized water, and dried 
with dry nitrogen. Amplitude and phase images as well as height images were collected for the 
same sample area. False-color height images were subsequently superimposed over either 
amplitude or phase images. 
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Part II: Prion-like Self- Replication of Amyloids 
 
Chapter 4 
Prion-like Self-Replications of Lysozyme Amyloids from Native Monomers in Vitro 
 
4.1. Introduction  
Self-assembly of proteins into fibrillar aggregates with cross-β sheet structures is the 
molecular hallmark of amyloid diseases, including Alzheimer’s disease, type II diabetes, and prion 
diseases [Eisenberg and Jucker, 2012]. Studies have implicated globular oligomeric intermediates 
as the most toxic amyloid species [Laganowsky et al., 2012; Kayed et al., 2004; Campioni et al., 
2010]. The biophysical/biochemical characterization of these intermediate amyloid oligomers has 
been limited due to their transient and short-lived nature [Bitan, 2006]. This raises the question 
whether and how these short-lived species can initiate the various pathologies associated with 
amyloid diseases. However, our presumption about the stability and activity in cells/tissues of 
various amyloid aggregates are mostly based on in vitro assays of amyloid assembly performed 
under the partially denatured conditions required to initiate fibril growth [Uversky et al., 2006, 
Uversky et al., 2004]. For instance, for folded proteins like the amyloid protein lysozyme, the 
common presumption is that fibril growth requires the presence of at least partially denatured 
monomers. The difficulties of identifying amyloid proteins capable of forming fibrils under near-
physiological conditions have raised the broader questions how do these diseases emerge under 
physiological conditions. Comparatively little is known whether pre-formed aggregates remain 
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stable under physiological conditions instead of dissolving or precipitating and whether they are 
capable of seeding growth from native monomers. One exception from this rule are prion proteins. 
Prion proteins are characterized by the ability of the protein aggregates (infectious particles) to self-
replicate from their native counterpart, resulting in multiplication and exponential propagation of 
the infectious particles. Both infectious prion diseases and amyloid diseases are characterized by the 
formation of amyloid fibrils that share basic morphological and structural features. This suggests 
that the molecular mechanisms underlying their formation could be closely related.  
In this study, we set out to investigate whether aOs, CFs, and RFs (explained in chapter 3) 
remained intact at physiological temperatures, and whether any of these aggregates could induce 
amyloid formation from natively folded monomers similar to prion proteins. To test our hypothesis 
we developed a two-step protocol: seed generation under denaturing conditions and prion-like 
propagation under native/physiological conditions. In the “seed generation” step, spontaneous 
amyloid formation is induced via transient and readily reversible thermal denaturation under near 
physiological conditions. This step mimics the yet poorly understood mechanisms of spontaneous 
formation of amyloid aggregates in vivo. The resulting aggregates are isolated from their 
monomeric background, and their amyloid characteristics as well as their stability under 
physiological conditions are explored. In the “prion like propagation” step, these pre-formed 
amyloid aggregates are seeded into a background of their native monomers under physiological 
conditions. The ability of these pre-formed seeds to undergo prion-like self-replication from their 
native proteins is assessed. For these experiments, we used  HEWL as our model amyloid (more 
information regarding the HEWL is described in section 1.4). Using a broad range of biophysical 
approaches, SLS, DLS, ThT fluorescence, FTIR,  AFM,  we investigated tinctorial, morphological, 
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and structural features of aggregates generated at physiological temperatures via prion-like self-
replication. This work was published in J. Am. Chem. Soc. (JACS), 136, 8947−8956 in 2014. 
4.2. Results and Discussion 
 The investigation into potential prion-like activity of lysozyme aggregates was motivated by 
the observation aOs or CFs growth continue albeit at very slow pace, long after solutions had been 
returned to room temperature. We therefore tested whether oligomers, CFs, and RFs remain intact 
and soluble upon return to physiological temperature and pH, and whether they developed prion-
like characteristics of self-replication from native substrate under these conditions. While we 
intended to confine these experiments to the physiological pH of 7, we found that we could use 
thermal denaturation of lysozyme only to produce aOs and CFs but not RFs. Therefore, pH 3 
conditions were included in the experiments, which allowed us to generate all three aggregates 
species by simply changing NaCl concentrations (described in chapter 3). We were aware of 
noticeable monomer hydrolysis at highly acidic pH, but at pH 3 and 37 0C the hydrolysis remained 
negligible [Mishra et al., 2007]. Equally important, pH 3 preserves the natively folded state of 
lysozyme at 37 0C and the cooperative unfolding of lysozyme’s secondary and tertiary structure 
near 70 0C. At more acidic pH, this cooperativity breaks down governing to partial loss of tertiary 
structure prior to secondary structure [Hazebrouck et al., 1995]. 
4.2.a. Amyloid Seed Formation via Transient Heat-shock and their Stability at Physiological 
Temperatures 
 To begin with, we generated aOs, CFs , or RFs seeds by incubating 1.4 mM of lysozyme at 
70 °C and either at pH 7 or pH 3.  This temperature is near the lower edge for the onset of partial 
denaturation of lysozyme at these pH values (Figure 4.1). This was confirmed using tryptophan 
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intrinsic fluorescence spectroscopy to monitor the unfolding of a protein’s tertiary structure. Due to 
the environment sensitivity of tryptophan (Trp) and/or Tyrosine (Tyr) fluorescence, the shift of the 
peak in the emission spectrum of Trp/Tyr, tracks the partial unfolding of proteins (Figure 4.1).  
 
Figure 4.1. Thermal Denaturation Profile of Lysozyme. Peak wavelength for lysozyme's intrinsic Trp 
fluorescence emission at pH 7 (n) or pH 3 (•) vs. temperature. The solid line represents a fit with a two-state 
model through the Trp data of HEWL at pH 7. Arrows indicate temperatures used for seed formation (70 °C) 
or for seeds stability and growth in the presence of native lysozyme (37° C). 
 
RFs or aOs/CFs were formed by incubating 1.4 mM lysozyme at 70 °C  and pH 3 with either 100 
mM or 250 mM NaCl, respectively.  Oligomers at pH 7 were generated by incubating 1.4 mM 
lysozyme with 40 mM NaCl at 70 °C for 1.5 hours or less. Past 2 hours CFs nucleated, with the 
proportion of CFs increasing with incubation period. In all cases, amyloid seed growth was 
monitored in situ using SLS and DLS. AFM images of amyloid aggregates generated at either pH 3 
or pH 7 showed the characteristic morphologies associated with either oligomers or CFs (Figure 
4.2a & b) or RFs (Figure 4.2c) of lysozyme. These aggregates also displayed the same kinetic, 
tinctorial, and structural properties features as those previously reported in chapter 3 of this 
dissertation. 
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Figure 4.2. Morphology of  Lysozyme Aggregates Grown at pH 3  and/or pH 7 under Denatured 
Conditions. AFM images of (a) lysozyme’s aOs generated during incubation of lysozyme at 70 °C and pH 7 
in 40 mM NaCl; (b) aOs and/or early stage CFs formed during incubation of lysozyme at 70 °C and pH 3 
and 250 mM NaCl or (c) RFs formed during incubation of HEWL at 70 °C and pH 3 and 100 mM NaCl. 
(Scale bar: 200 nm; color scale: aggregate height in nm). 
 
  Prior to investigation of prion-like features of lysozyme’s aggregates (seeds), we first 
established whether either these distinct aggregates remained stable when lowering solution 
temperatures back to 37 °C. To evaluate thermal stability of seeds in the absence of monomers, 
seeds were separated from their monomer background using a 50 kDa recovery filter and 
subsequently re-suspended in buffer (see materials and methods). Successful separation and 
integrity of seeds was confirmed using DLS and AFM imaging on the separated aggregates. 
Specifically, thermal stability at 37 °C is determined by re-suspending isolated seeds in buffer 
solutions and monitoring their scattering intensity and particle size distributions for a minimum of 
24 hrs. Amyloid filaments, which represent the aggregate morphology most commonly associated 
with amyloid diseases, remained stable at 37 °C (Figure 4.3a). For aOs and CFs we determined 
their thermal stability at 37 °C for both pH 3 and pH 7. At pH 3, aOs and CFs dissociated very 
    (a)                                               (b)                                             (c) 
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slowly, with a small monomer peak appearing around 10 hrs of incubation (Figure 4.3b). At pH 7, 
aOs/CFs remained stable (Figure 4.3c). 
 
        
Figure 4.3. Stability of Lysozyme aOs/CFs and RFs at Physiological Temperature. (a) Static light 
scattering (Iscat) of RFs at pH 3, indicating high stability at physiological temperatures; (b) Iscat of pH 3 
aOS/CFs indicating a very slow decay; (c) Iscat  of pH 7 aOs/CFs kept at 37 °C, indicating that they remain 
stable. Insets: particle size distributions obtained with DLS at the beginning (---) and end (__) of the 
incubation period. 
 
Dissociation rate of oligomers was sufficiently slow to consider these aggregates stable for the 
purpose of subsequent seeding experiments at pH 3. At pH 7, aOs/CFs (Figure 4.3c) showed no 
signs of decay or self-assembly. The stability of aOs/CFs is particularly surprising since these types 
of aggregates are typically considered metastable and transient intermediates of the aggregation 
process under denaturing conditions [Miti et al., 2015]. Upon lowering solution temperature to 
physiological values, both aOs and CFs became either long-lived (pH 3) or stable (pH 7) states.  As 
highlighted by recent experiments on tau filaments, and transthyretin oligomers/CFs the thermal 
stability of amyloid aggregates is not self-evident either [Luo et al., 2013; Pires et al., 2012]. Our 
data indicate that isolated lysozyme aOs, CFs, and RFs are either stable or at a minimum, have 
dramatically reduced their rates of dissociation, fragmentation or self-association when lowering 
    (a)                                                     (b)                                                (c) 
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temperatures into the physiological range. The stability of different amyloid species, in particular 
amyloid oligomers and CFs close to physiological conditions is relevant to the question how 
supposedly short-lived and/or metastable amyloid species can propagate/spread within tissues or the 
entire body, or even from one individual to another. 
 
4.2.b. Prion-like Self-replication of aOs/CFs vs. RFs Near Physiological Conditions 
  In chapter 3, we have documented that at denaturing temperatures (used here for seed 
growth), aOs, CFs, and RFs all grow from denatured lysozyme monomers. The above data (Figure 
4.3) established seeds stability at physiological temperatures as an important prerequisite for testing  
their prion-like self-replication. We next tested whether these long-lived amyloid species could 
induce fresh amyloid growth when added to native lysozyme maintained at physiological 
temperatures. Amyloid seeds of either type were diluted 10-fold into solutions of native lysozyme 
using the same solution composition as during seed formation, but maintaining physiological 
temperature throughout. Figure 4.4a displays the changes in particle size distribution obtained from 
DLS of lysozyme’s fresh monomers seeded with amyloid aOs and CFs (~40 nm peak) at pH 3. 
After the native lysozyme solution is seeded with mixture of aOs and CFs, growth is observed 
(Figure 4.4b & 4.4c), as confirmed by enhancement in scattering intensity (Figure 4.4b) and 
associated changes in relative intensity for the CFs peak (Figure 4.4c). For a given sample, within 
18 hrs of incubation period, the scattering intensity more than doubled. This data suggests that 
oligomers and CFs can self-replicate from native monomers in a “prion-like fashion”. 
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Figure 4.4. Lysozyme aOs & CFs induce Amyloid Growth of Native Lysozyme at pH 3 and 37 °C. (a) 
Particle size distribution (PSD) of monomers seeded with a mixture of aOs (merged with monomer peak) 
and CFs (40nm peak). Within 18 hours (b) the scattering intensity from samples seeded with aOs / CFs more 
than doubled. At the same time (c) the CFs peak grew at the expense of the monomer peak M. 
 
In contrast, when we used RFs as seeds in lysozyme solution, no discernible growth was observed. 
The particle size distribution of fresh lysozyme solution seeded with RFs is shown in Figure 4.5a. 
Lack of growth is documented by lack of changes in either scattered intensity (Figure 4.5b) or 
relative peak area percentages (Figure 4.5c) for over 3 days of incubation period at 37 °C. This 
indicates that at physiological temperatures, although RFs display high stability, they cannot induce 
native lysozyme growth via prion-like self-replication. It is worth recalling that at 37 °C, lysozyme 
assumes its natively folded state. Therefore, the ability of oligomers and CFs to seed fresh growth at 
37 °C, combined with the inability of RFs to do so, implies the absence of even small percentages 
of partially unfolded monomers in solution, which would support growth of either template. 
 
 
 
(a)                                             (b)                                             (c) 
M/aOs 
CFs 
CFs 
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Figure 4.5. Lysozyme RFs do not Induce Amyloid Growth of Native Lysozyme at pH 3 and 37 °C. (a) 
Particle size distributions of lysozyme sample seeded with RFs. The S-RF and L-RF peaks in (a) correspond 
to the short and long rigid filaments formed in this assembly pathway. Monomer solutions seeded with RFs 
displayed no changes in (b) scattering intensity or (c) size distribution during 3 days of incubation. 
 
 
To ensure that monomers remain natively folded and amyloid self-replication is not due to 
possible presence of partially unfolded monomers at acidic pH, we repeated the seeding 
experiments near physiological pH of 7. Oligomers or mixtures of oligomers and CFs at various 
stages of self-assembly generated at elevated temperatures (70 °C) were diluted 5 to 20 fold into 1.4 
mM of fresh lysozyme, and maintaining the temperature at 37 °C. We incubated seeded solution for 
a period ranging from 4 days to 2 weeks. Solutions of native lysozyme at 37 °C seeded with 
oligomers only (Figure 4.6a) displayed kinetic growth signatures similar to those for barrier-free 
oligomer formation at denaturing temperatures (explained in chapter 3), albeit at much reduced 
growth rates (Figure 4.6b and 4.6c). The observed growth kinetics includes a prominent nucleation 
event associated with protofibril nucleation (Figure 4.6b) and significant acceleration in 
enhancement of the scattered intensity after the appearance of CFs peak (Figure 4.6c). In addition, 
we tested the seeding capability of CFs. Seeding lysozyme monomers with mixtures of CFs and 
aOs (Figure 4.6d) resulted in noticeably faster increases in scattered intensity (Figure 4.6f). These 
   (a)                                                (b)                                              (c) 
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results together (Figures 4.4-4.6) suggest that aOs and CFs but not RFs induce prion-like growth 
from natively folded monomers. Our goal was to perform all seeding experiments at pH 7 and 37o C 
since these conditions represents the most biomedical relevant scenario. However, we could only 
generate aOs and CFs, but not RFs at pH 7. Therefore, we tested whether amyloid templates 
generated at pH 3 remain stable upon shift to pH 7. If aOs/CFs and RFs could be successfully 
stabilized at physiological pH, in principle this would permit us to test prion-like behavior for either 
type of amyloid aggregates at pH 7. 
 
Figure 4.6. Native Lysozyme Seeded with aOs and CFs near Physiological Conditions. Particle size 
distribution is derived from DLS measurements for solutions of lysozyme monomers at pH 7 seeded with 
20% (v/v) of (a) aOs or (d) mixtures of aOs and CFs. Peak labels (M/aOs) and (CFs) indicate the 
monomer/oligomer peak and CFs peak respectively. The distribution of monomers alone in (a) is indicated 
by dashed curve. Temporal evolution in the peak size for samples seeded with either oligomers (b) or 
mixture of oligomers and CFs (e). Panel (b) indicates nucleation CFs after 6 hr of incubation. Growth is 
documented by corresponding changes in scattered intensity for samples seeded with either aOs (c) or 
mixture of oligomers and CFs (f).  
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For that purpose, CFs and RFs were generated at pH 3 as described above and then either directly 
transferred or dialyzed to pH 7 buffer and separated from their monomeric background. Our 
observation indicated that oligomers and CFs at any stage of assembly at pH 3 irreversibly 
precipitated in solution at pH 7. RFs also showed sign of precipitations when directly brought from 
pH 3 to pH 7. However, we were able to stabilized RFs in pH 7 solution after dialyzing and filtering 
the resulting solution through 0.8µm pore syringe filters. Prior to seeding experiment, re-solubilized 
filaments at pH 7 were re-concentrated to 20 mg/mL and then seeded into fresh lysozyme at pH 7 
and 37 °C. Our findings suggest that although RFs were stable at pH 7 they did not show any sign 
of growth in presence of native monomers (Figure 4.7). Lack of growth in seeding experiment with 
RFs is confirmed by lack of enhancement in either scattered light (Figure 4.7a) or ThT emission 
intensity (Figure 4.7b). 
 
 
Figure 4.7. RFs do not Self-replicate from Native Monomers at pH 7. RFs seeds, generated at pH 3, 
separated from monomers, dialyzed, and re-solubilized at pH 7. After concentrating seeds to 20 mg/mL, 10% 
(v.v) of seeds were re-suspended into either 20 mg/mL of native lysozyme ( ) or buffer only (pH 7, 40 mM 
NaCl) (■). Samples were incubated at 37 °C. (a) Lack of growth of lysozyme monomers  seeded with RFs is 
indicated by their steady scattering intensity ( ) and (b) ThT fluorescence emission measured initially (---) 
and at the end (__) of the incubation period. In contrast, CFs generated at pH 7, and seeded in lysozyme 
monomeric solution (10% seeds), readily induce growth as indicated by light scattering (ο).  
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As a control Figure, 4.7.a shows the ability of CFs generated at pH 7 to induce prion-like self-
replication growth under the same conditions. 
 
To explore whether the observed growth at physiological conditions indeed represented prion-
like self-replication of aOs/CFs from native monomers, or possible self-assembly of seeds and/or 
spontaneous growth of native monomers we performed a set of control experiments. For these and 
subsequent experiments we maintained physiological pH and temperatures, since it represents the 
most bio-medically relevant situation. Fresh native lysozyme monomers incubated at 37 °C and pH 
7 without seeds displayed no sign of aggregation for 3 months (data is shown for one month) of 
incubation (Figure 4.8a).  
 
                          
 
Figure 4.8. Control Experimens confirming that Prion-like Growth Requires both aOs/CFs and Native 
Monomers. (a) Lack of aggregation for Lysozyme monomers  incubated at pH 7, and 37 °C (20 mM Hepes, 
40 mM NaCl) for one month is documented by lack of changes in their hydrodynamic radius Rh  (ο) or light 
scattering intensity Iscat (■) (b) aOs/CFs but not pre-heated monomers induced aggregation of native 
lysozyme, as indicated  by changes in light scattering for lysozyme monomers  incubated with 20% of either 
isolated CFs(●) or heat-treated  monomers (ο) separated from each other. 
 
We already established (Figure 4.3c) that isolated aOs or CFs in the absence of lysozyme 
monomers did not display any tendency towards self-assembly or dissociation when incubated at 
physiological temperatures. We further tested whether partially unfolded monomers, generated 
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during seed formation would induce growth of native monomers. For that purpose, we seeded fresh 
monomers with heat-exposed monomers after they were separated from aOs/CFs. Both aOs/CFs 
and pre-heated monomers were brought to identical concentration and seeding experiment at 37 oC 
was performed. Our static light scattering data suggests that pre-heated monomers did not induce 
growth, while immediate growth is registered in the sample seeded with aOs/CFs ( Figure 4.8b). 
Furthermore, to assess whether seeded growth consumes fresh monomers in the growth process, we 
determined the concentrations of free monomers as a function of incubation period. Using 
ultracentrifugation, we pellet the aggregates from aliquots of growth solution and measure the 
monomer concentration in the supernatant at different time points during growth. As shown in 
Figure 4.9a, aggregation induced via prion-like self-replication depleted monomers to levels far 
exceeding the original seed concentration (10% v/v). Monomer depletion correlated with increases 
in scattering intensity measured just prior to ultracentrifugation is shown in Figure 4.9a. We further 
tested whether protein hydrolysis could generate partially denatured states of native lysozyme under 
our incubation condition which would drive subsequent amyloid aggregation. SDS-PAGE gel 
electrophoresis under reducing conditions indicates that lysozyme hydrolysis is undetectable even 
when incubating lysozyme for periods of up to 3 months at 37 °C (Fig. 4.9b). While hydrolysis is 
noticeable for high-temperature incubation at pH 2 (positive control), lysozyme showed no 
discernible signs of hydrolysis during seed growth (pH 7, 70 °C) for up to 6 hrs, a sufficient time 
for the seed growth. These control experiments together document that neither native lysozyme 
monomers nor aOs/CFs seeds self-assemble by themselves. In addition, prion-like self-replication 
depleted fresh monomers. Hydrolysis was not noticeable under conditions used for our experiments. 
All of the above-mention control experiments together indicated that the observed aggregation 
required both amyloid seeds and native monomers to proceed. Therefore, aOs, and CFs but not RFs 
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were able to induce aggregation of native lysozyme via prion-like self-replication at 370C. The 
observed signature in particle size distributions (from DLS) and scattering intensities ( from SLS) 
of seeded growth at physiological temperatures reported here replicated many of the distinct kinetic 
features reported during the growth of different proteins under denaturing conditions [Arnaudov et 
al., 2005]. Particularly, the temporal evolution of the particle size distributions; slow enhancement 
of scattering intensity prior to CFs formation; slow increase in mean CFs hydrodynamic radius; 
exponential growth in scattering intensity are associated with lysozyme’s fibril growth along the 
oligomeric pathway at denaturing temperatures (see chapter 3 for details).  
 
             
Figure 4.9. Control Experiments Confirming That Prion-like Growth Depletes Native Monomers  and 
no Hydrolysis is Observed Under These Growth Conditions. (a) Prion-like self-replication of  aOs/CFs 
depletes fresh monomers ( initial concentration 20 mg/ml). In this seeding experiment, 10% (v/v) early-stage 
CFs, separated from their monomers were incubated at 37 °C. Residual measured after centrifugation for 2 
hrs at 98,000 g, monomer concentrations in the supernatant (■) is determined via UV spectroscopy. Light 
scattering intensities (○) from aliquots of seeded solution were measured prior to centrifugation for about 4.2 
days. After 4.2 days, DLS measurements were excluded since the sample started gelling out. (b) Reducing 
SDS-PAGE gel of lysozyme (lane 2) incubated at pH 2 / 70 °C as positive control for hydrolysis (lane 3) 
incubated under seed propagation conditions ( pH 7 / 37 °C) for 90 days (lane 4-7) incubated under seed 
formation conditions (pH 7 / 70 °C) for typical periods used during seed growth. The lane 1 represents MW 
marker in kDa. SDS-PAGE gel shows  no sign of hydrolyses under the above-mentioned growth conditions. 
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4.2.c. Morphological, Tinctorial and Structural Analysis of Aggregates Derived via Prion-like Self-
replication near Physiological Conditions 
 Our DLS and SLS data suggest the prion-like self- replication of amyloid aOs/CFs but not 
RFs from natively folded lysozyme monomers. One of the features of prion-like replication is that 
newly generated aggregates preserve the structural characteristics of their seeds. Therefore, we 
compared the aggregates' morphological, tinctorial and structural characteristics to those for 
aOs/CFs grown at denaturing temperatures. AFM images of lysozyme oligomers used for seeding 
experiment and aggregates generated via prion-like self-replication at physiological temperature 
and pH are shown in Figure 4.10.  
               (a)                                       (b)                                       (c)                                                                                                                                                             
            
Figure 4.10. Amyloid Aggregates Grown via Seeding Experiment at Physiological Temperature and 
pH Display Typical Morphologies of aOs and CFs. (a)  AFM images of  oligomeric seeds (a), and 
resulting early-stage CFs after 5 days incubation (b) or and late stage CFs after 3 weeks of incubation (c) 
grown via seeding of native lysozyme at pH 7 and 37 °C. (scale bar: 200 nm; false color scale: height in nm). 
 
AFM images of seeds display typical morphologies of globular aOs (Figure 4.10a). The 
morphologies of aggregates formed after incubation with fresh native lysozyme at 37 °C for 5 days 
and 3 weeks are shown in Figure 4.10b and 4.10c respectively.  
 The amyloid character of aggregates obtained via prion-like self-replication was confirmed 
using ThT fluorescence, a well-established amyloid indicator dye. We monitored enhancement of 
ThT response over the incubation period, and compared the fractional enhancements to those of the 
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light scattering. For a given sample, fractional increases in light scattering vs. ThT fluorescence 
intensity during incubation were of comparable magnitude (Figure 4.11a). As we discussed in 
chapter 3, this feature is characteristic aOs/CFs growth at denaturing temperatures. To assess the 
secondary structure of aggregates generated via prion-like self-replication, we relied  on FTIR. 
Figure 4.11b displays difference spectra of the Amide-I band obtained by subtraction of aggregates’ 
spectra from those of native lysozyme.    
 
                     (a)                                                                     (b)       
 
       
 
Figure 4.11. Aggregates Generated via Prion-like Self-replication Share Structural Properties with 
aOs/CFs Generated at Denaturing Solution Conditions. (a) Fractional enhancement in ThT fluorescence 
emission (n) and light scattering intensity (l) during the growth of lysozyme via prion-like self-replication 
(b)  Normalized FTIR difference spectra within the Amide I band for late-stage amyloid aggregates at pH 7 
formed after incubation at either 70 °C 8 hr or 37 °C for 5 days , after subtraction of the corresponding  
spectra for lysozyme monomers. Notice the identical patterns of increases in β-sheet content and loss of α-
helical structures for either growth condition. 
 
The spectra of aggregates generated via self-replication at physiological temperature are compared 
with those of aggregates generated at denaturing conditions and (70oC). Figure 4.11b indicates an 
increase in amyloid associated  β-sheet (1618 cm -1) content and a loss of α-helical (~1660 cm -1) 
structures for either growth condition. Notice, the 1610-1630 cm-1 β-sheet peak is considered 
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diagnostic of amyloid assembly [Zandomeneghi et al., 2004]. Figure 4.11b demonstrates that there 
is no discernible difference in the structure of aggregates grown via prion-like self-replication vs. 
those obtained via thermal denaturation. We also found a weak peak emerging near 1,695 cm-1, 
which has been associated with anti-parallel β-sheets in Aβ aOs [Cerf et al., 2009]. The above-
mentioned morphological, tinctorial, and structural characteristics documents that aggregates 
formed at physiological conditions via prion-like self-replication of aOs/CFs from native lysozyme 
are indistinguishable from aOs and CFs grown from partially denatured lysozyme. 
 
4.2.d.  Dependence of Growth Kinetics on Seed Age and Monomer Concentration 
  To describe amyloid self-assembly, three major models have been considered widely: 
templated assembly (TA) [Griffith, 1967], nucleated polymerization (NP) [Harper et al., 1997] with 
two variants including secondary mechanisms for aggregate formation via fragmentation (NP-F), 
and secondary nucleation (NP-SP) [Cohen et al., 2012], and nucleated conformational conversion 
(NCC) [Lee et al., 2011; Serio et al., 2000]. A more detailed explanation of these models is 
provided in section 1.6 of this dissertation. 
 We explored the aOs/CFs growth dependence on seed age and monomer concentration 
under native solution conditions. This dependence could provide some insight about the model that 
is consistent with our data. To begin with, a fixed concentration of lysozyme monomers was seeded 
with aOs, early-stage curvilinear fibrils (ECFs) or late-stage curvilinear fibrils (LCFs). Figure 4.12a 
shows a semi-log plot of the enhancement in scattering intensity of lysozyme monomer solution 
seeded with either aOs, ECFs or LCFs for over 2 weeks of incubation. The logarithmic data is fitted 
using a linear function, indicating that seeded growth from native monomers accelerates 
exponentially in time.  Such exponential increases in scattered light implies the action of a 
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mechanism for self-replicating growth units proportional to those already present (dN ∞ N(t)), 
similar to fragmentation or secondary nucleation [Masel et al., 1999; Cohen et al., 2012]. Such 
exponential growth is a typical characteristic of prion propagation. Figure 4.12a (curve aOs) 
indicates that growth seeded with oligomers only displayed a dramatic increase in the exponential 
growth rate after near 5 days of incubation. This period coincided with the nucleation of CFs 
reported by DLS. Increases in growth rate upon CFs nucleation, suggests that mechanism of prion-
like self-replication becomes either more efficient or an additional mechanism is activated after CFs 
nucleation. 
 
Figure 4.12. Dependence of Growth Kinetics on Seed Age and Monomer Concentration.(a) Natural 
logarithm of the scattering intensity (Iscat) for solutions of native lysozyme incubated at 37 °C, pH 7 with 20 
% of aOs, early-stage curvilinear fibrils (ECFs) or late-stage curvilinear fibrils (LCFs). Solid lines are 
exponential fits to the data with growth rate τ in days as indicated.  The break in the growth rate for the 
oligomer-seeded sample (aOs) coincided with the nucleation of CFs. (b) Log-log plot of the aggregate 
growth rate for solutions of 10% (v/v) of isolated protofibrils seeded into increasing concentrations of 
lysozyme monomers (0.2 - 20 mg/ml).  Aggregation rates for each sample were equated to the slope of the 
fractional increases in scattering intensity near the onset of growth.  A power law fit through the data (---) 
yielded an exponent of 0.85±0.16. 
 
Dependence of growth rate on seed age/maturity   suggests that the efficacy of this mechanism 
might also increase potentially through an increase in CFs’ contour length. The mechanism of self-
replication is explored further by testing the dependence of growth on monomer concentration 
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while seed concentration and age is held fixed. Figure, 4.12b shows a log-log plot of measured 
growth rates as a function of monomer concentration. The lysozyme monomer samples were seeded 
with 10% (v/v) of CFs from the same seeds stock solution. The observed growth rates were nearly 
proportional to monomer concentration (power law exponent 0.85±0.15) over two orders of 
magnitude in monomer concentration. Surprisingly, no signs of saturation at high monomer 
concentrations or a discernible zero-point off-set at low monomer concentrations is observed. The 
TA model implies growth rates saturate at elevated monomer concentrations since growth is limited 
by template concentration. Therefore, the TA model is out of consideration here. The absence of 
fragmentation is indicated from the stability of isolated CFs when dissolved in buffer (see Figure 
4.3c). Furthermore, fragmentation would imply a strong dependence on aggregates but not 
monomer concentration [Cohen et al., 2012]. Finally, the lack of a finite threshold to activate the 
self-replication process is at odds with any nucleated process since the latter requires a finite 
driving force (i.e. supersaturation). The lack of amyloid formation by native monomers in the 
absence of seeds (Figure 4.7a), the lack of any lag phase for oligomer formation under denaturing 
(seed growth) conditions, the immediate onset of growth from native monomers upon even modest 
seed addition all imply that variants of nucleated polymerization and nucleated conformational 
conversion, by themselves, are difficult to reconcile with the growth process reported here. 
 
4.2.e. Orthogonal Self-Replication and Nucleated Polymerization Model 
 Our prion-like self-replication growth from native monomers doesn’t fit well with existing 
models. The above discrepancies with existing models compelled us to propose a new model to 
describe prion-like self-replication. Features this model attempts to incorporate are: exponential 
growth when seeding native monomers with preformed oligomers, no discernible threshold for the 
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onset of the oligomer formation, presence of a nucleation barrier for CFs aggregation, lack of 
spontaneous aOs/CFs formation from native monomers, and structural similarities between aOs and 
CFs (as discussed in chapter 3). Incorporation of these features suggests the presence of  two 
distinct “activities” of oligomers and protofibrils that operate “orthogonal” to each other. These 
“activities” include: self-replication of oligomers from native monomers via a mechanism 
resembling a bimolecular reaction combined with nucleated polymerization of CFs from oligomers, 
which resembles nucleated phase growth.  
 The aggregation behavior for aOs/CFs vs those of RFs at denaturing vs native temperatures 
are summarized in Figure 4.13. At denaturing temperatures, amyloid RFs growth proceeds via 
nucleated polymerization, with likely contributions from secondary nucleation. At physiological 
temperatures, these filaments are stable against fragmentation or dissociation. However, these RFs 
did neither nucleate nor grow from native monomers at physiological temperatures. During 
oligomeric assembly pathway at partially elevated temperatures, oligomer formation occurs from 
denatured monomers. Under denaturing conditions the ability for self-replication is concealed by 
the high rate of spontaneous oligomer assembly from denatured monomers. Lack of a lag phase or 
prominent nucleation event during oligomer formation suggests that oligomers form via barrier-free 
self-assembly and in turn, undergo nucleated polymerization. At physiological temperatures, no 
spontaneous formation of oligomers from monomers at even the highest monomer concentrations is 
observed, arguing against a phase separation process. However, adding preformed oligomers into 
native monomeric solution results in their self-replication from native monomers. Similar to 
enzymes acting on their substrate, this autocatalytic self-replication mechanism has no discernible 
substrate threshold. Self-replication, in turn, accounts for the lack of a saturation threshold at high 
substrate concentrations. In addition, CFs polymerization uses oligomers as their growth substrate 
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and proceeds at a site distinct from that for self-replication. Based on calibrated AFM 
measurements, it has been shown that oligomers and CFs have identical cross-sectional areas, 
indicating that oligomers, not monomers, are the growth substrate for lysozyme CFs [Hill et al., 
2009]. With oligomers as their growth substrate, and the lack of CFs fragmentation, CFs can only 
continue to self-replicate in the presence of native monomers if they provide two distinct sites: one 
for generating oligomers from native monomers and another for using them as a substrate for 
elongation. 
 
Figure 4.13. Amyloid Growth at Denaturing vs. Native Temperatures: Oligomeric Assembly vs. 
Filamentous Pathway.  Schematic of the free energy landscape for oligomeric (left column) vs. filamentous 
(right column) amyloid growth at denaturing (top row) vs. physiological (bottom row) temperatures. Solid 
arrows indicate spontaneous assembly while dashed lines represent nucleated processes.  At denaturing 
temperatures, lysozyme oligomers form spontaneously from denatured monomers.  Those oligomers become 
the substrate for subsequent nucleation and polymerization of CFs. Amyloid rigid filaments, in contrast, 
directly nucleate and grow from denatured monomers. At physiological temperatures, neither oligomers nor 
RFs will form spontaneously from native monomers. However, pre-formed oligomers can self-replicate from 
native monomers. Once formed, oligomers support CFs nucleation and growth just as at denaturing 
temperatures. In contrast, RFs can't utilize native monomers as growth substrate and their growth becomes 
arrested. 
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Such uncoupling of activities is also supported by the observation that CFs formation is a nucleated 
process while replication of oligomer from either oligomeric or CFs seeds will proceed without a 
threshold. Our observations on lysozyme amyloid formation at denaturing vs. physiological 
temperatures reveal significant differences to the thermodynamic stability, solubility, and 
aggregation propensity of oligomeric vs. RFs amyloid aggregates under these two conditions. All 
this suggests two distinct mechanisms of oligomeric formation at partially denatured vs. 
physiological temperatures. While oligomer assembly at denatured temperatures occurs from 
partially denatured monomers, at physiological temperatures, oligomer formation occurs via 
autocatalytic self-replication from natively folded monomers.   
4.3. Summary   
RFs and aOs/CFs of lysozyme either reduced their rate of dissociation/fragmentation or 
completely stabilized at physiological temperatures. The stability of different amyloid species, in 
particular aOs and CFs close to physiological conditions is relevant to the question how supposedly 
short-lived and/or metastable amyloid species might spread to other cells and tissues, and 
potentially promote formation of new amyloid growth there. Our data suggests that only aOs and 
CFs were able to induce autocatalytic self-replication from natively folded lysozyme. The ability of 
aOs and CFs, but not RFs, to seed growth at native temperatures highlights that seeded amyloid 
formation by native proteins not only depends on monomer stability and structure but on the 
stability and structure of amyloid templates and their interactions with native monomers. It further 
implies that only a subset of amyloid aggregates might have the capacity for self-replication 
required for their prion-like propagation in tissue [Prusiner et al., 2012]. Lack of growth of RFs at 
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physiological temperatures and growth at denaturing temperatures implies that filaments require 
denatured monomers as growth substrate.  
 In chapter 3 of this dissertation, we documented that lysozyme RFs, aOs and CFs all 
develop β-sheet peaks in the Amide-I region of their FTIR spectra. While all lysozyme aggregates 
displayed amyloid-like structure, they also had distinguishable structural characteristics. These 
differences might well correlate with the β-sheet rich but distinct structures reported for amyloid 
filaments vs. oligomers reported for model peptides [Nelson et al., 2005].  The ability of oligomers 
and their polymers for self-replication from native protein further add to the growing list of 
pathogenic features ascribed to this class of amyloid aggregates [Campioni et al., 2010; Kayed et 
al., 2004; Condron et al., 2011]. Prion-like self-replication of aOs/CFs is consistent with 
characteristics of prion proteins: in vitro self-replication [Griffith 1967].  
Our orthogonal self-replication and nucleated polymerization model shares important 
similarities with basic aspects of the previously known models.  Oligomer formation via prion-like 
self-replication proceeds spontaneously. No threshold for onset or signs of saturation at high protein 
concentrations is observed. The lack of saturation is a simple consequence of the autocatalytic 
feedback cycle in which the product of one replication cycle serves as the "enzyme" in the next 
cycle. Most prominently, self-replication provides a mechanism for exponential growth of 
aggregate populations. Furthermore, in our model the aOs self-replication and CFs elongation 
utilize different growth substrates: while native monomers are the substrate for aOs self-replication, 
CFs nucleation and polymerization utilizes aOs. The separation of self-replication and elongation 
allows these two processes to proceed in a coordinated fashion that feeds back onto each other. 
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Overall, we documented that the process of amyloid fibril assembly, while displaying 
various generic aspects, might proceed through a variety of different pathways. Multiple assembly 
mechanisms which become dominant not just by changes in monomer structure but by the type of 
amyloid aggregate formed and its specific propensity to interact with various monomeric 
conformations under various solution conditions.  Such diversity of mechanisms might help ex-
plain the wide variety of phenotypes and aggregation behavior reported for both functional 
amyloids and pathological amyloids. 
4.4. Materials and Methods 
4.4.a. Protein and Chemicals  
Two times recrystallized, dialyzed, and lyophilized hen egg white lysozyme (hew-L) was purchased 
from Worthington Bio-chemicals (Lakewood NJ) and used for all experiments. Ultrapure grade 
thioflavin T was obtained from Anaspec (Freemont, CA). All other chemicals were purchased from 
Fisher Scientific (Pittsburgh, PA) and were reagent grade or better.  
 
4.4.b Preparation and Isolation of Amyloid Seeds.  
Typically, hew-L was dissolved in 20 mM HEPES at pH 7 or 10 mM of sodium citrate at pH 3 and 
filtered consecutively through 220 and 50 nm syringe filters. Lysozyme concentrations were 
determined from UV absorption using a280 = 2.64 mL mg−1 cm−1. For oligomer/CFs formation at pH 
7, solutions were incubated with either 40 or 80 mM NaCl at 70 °C for 1.5−6 h. At pH 3, 
oligomer/protofibril formation was induced by incubation lysozyme with 250 mM NaCl at 70 °C 
for 4−10 h. For amyloid filament growth, solutions were incubated at pH 3 with 75−100 mM NaCL 
for 20−30 h. Seeds were separated from lysozyme monomers using 50 kDa MW centricon filters, 
spun at 14000 g, and rinsed multiple times with the appropriate growth buffer. 100−150 µL of 
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isolated seeds in buffer were collected from the top reservoir of the filter, and the seed 
concentration was determined from UV absorption.  
 
4.4.c. Aggregate Stability and Seeded Growth Experiments 
For seed growth experiments, native lysozyme solutions were mixed with 5−20% (v/v) of amyloid 
seed solutions and incubated for 5−14 days. For seed stability experiments, oligomers/CFs were 
added at 10−20% (v/v) to buffer and incubated up to 50 h, and up to 100 h for RFs. For experiment 
on monomeric dependence of seeded oligomer/CFs growth, 10% of isolated seeds were incubated 
with 0.2−20 mg/mL of monomeric lysozyme solution at 37 °C and pH 7. For cross-seeding 
experiments, CFs and  RFs generated at pH 3 were separated from monomers and brought to pH 3 
via dialysis against pH 7 buffer. CFs at various stages of growth irreversibly precipitated upon 
buffer exchange. Amyloid RFs also tended to precipitate but, after passing through 0.8 µm syringe 
filters, resolubilized. These fibrils were concentrated to 20 mg/mL right before seeding with fresh 
monomers at pH 7.  
4.4.d. Gel Electrophoresis 
SDS-PAGE gel electrophoresis was performed using 10-20% gradient Tris-tricine gels (Criterion, 
Bio-Rad) and a sodium dodecyl sulfate (SDS) running buffer without glycine.  An aliquot of 20 µg 
was mixed with Laemmli sample buffer (Bio-Rad) with the reducing agent β-mercapto-ethanol. 
Samples were boiled for 5 min, loaded onto precast gels, and stained with BioSafe Coomassie (Bio-
Rad) per manufacturer's instructions.   
Summarized description regarding the SLS, DLS, ThT fluorescence spectroscopy, FTIR, 
and AFM is provided in section 3.4. 
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Chapter 5 
Prion-like Self-replication of Transthyretin Amyloids from Native Tetramers in Vitro 
 
5.1 Introduction 
Amyloid oligomers (aOs) are the first morphologically distinct species observed in the 
transthyretin (TTR) aggregation pathway [Pires et al., 2012], and these intermediates in the case of 
TTR mutants display toxic characteristics [Sousa et al., 2001]. Transthyretin (TTR) is a soluble 
plasma protein, which transports thyroxine and rethinol [Costa et al., 1978]. It is a homo-tetramer of 
55 kDa, composed of four identical 127-residue monomers. More than 100 TTR mutations are 
known, and both wild type and most mutations have been shown to be “amyloidogenic” [Hou et al., 
2007; Sousa et al., 2001]. Wild type TTR (wt-TTR) is responsible for senile systemic amyloidoses 
(SSA), an age related disease [Westermark et al., 1990; Lai et al., 1996] characterized by protein 
depositions and pathology in the heart after age 60. SSA is estimated to affect over 25% of the 
population over age 80 [Westermark et al., 1990; Lai et al., 1996]. Amyloid formation by over 70 
TTR variants is associated with familial amyloid polyneuropathy (FAP), characterized by 
neuropathy and/or organ dysfunction [Quintas et al., 1999; Saraiva et al., 1995]. In vitro 
experiments have indicated that TTR amyloid fibril formation requires the dissociation of the native 
TTR tetramer into a non-native monomer state prone to aggregation [Lai et al., 1996]. Small 
molecules that stabilize native tetramers abolish TTR fibril formation, thereby supporting the 
hypothesis that tetramer dissociation is a prerequisite of amyloid assembly in this system 
[Schneider et al., 2001]. However, typical in vitro experiments have evaluated TTR aggregation in 
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vitro using low pH values between two and five. This raises the question whether the mechanisms 
observed for TTR amyloid formation under harsh in vitro conditions match those active in vivo.  
Although the mechanism of self-replication and transmissibility is only established for prion 
diseases, the concept of “prion-like self-replication” is being investigated in multiple neuro- 
degenerative diseases. In transgenic mouse models, it has been demonstrated that Aβ can be seeded 
by inoculation with misfolded protein via a mechanism that closely resembles the molecular 
templating of prions [Jucker & Walker, 2011; Kane et al., 2000]. Whether prion-like self-
replication mechanisms are relevant in other degenerative disease is not clear yet.  As discussed in 
chapter 4, we recently developed a two-step protocol to assess the capacity of different amyloid 
aggregate species (aOs, CFs, RFs) to undergo prion-like self-replication from their native 
counterparts in vitro and under physiological conditions. We established the validity of this protocol 
using the model HEWL. Lysozyme’s aOs and CFs grown near physiological conditions were 
capable of prion-like self-replication. In contrast, RFs, which required acidic growth conditions, 
showed no sign of self-replication [Mulaj et al., 2014]. Beyond their known toxicity, the capacities 
for prion-like self-replication and propagation, might represent yet another important distinction in 
the biological activities of aO/CFs vs. RFs.  
Using biophysical/biochemical approaches, we extended our study to assess the potential for 
prion-like replication of amyloid aggregates of the human amyloid protein transthyretin (TTR). 
Initially we generated TTR aOs/CFs via heat shocking. The morphology and amyloid character of 
these aggregates was explored using AFM and ThT fluorescence, respectively. These pre-formed, 
well characterized and isolated aggregates were seeded into native TTR solution. We then explored 
the capacity of isolated aOs/CFs to self-replicate from native tetramers in a “prion-like manner”. In 
addition, we investigated whether aOs and CFs generated via prion-like self-replication preserved 
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the structural, tinctorial, and morphological characteristics of those generated at denaturing 
conditions. These findings enrich the mechanistic understanding of the biophysical mechanisms 
governing the formation and spread of amyloid aggregates, and might open venues to isolate the 
structural determinations of prion species that underlie their autocatalytic activity.  
 
5.2. Results and Discussion 
Studies persistently show that TTR amyloid aggregation is induced by destabilizing native 
tetramers either via denaturation at elevated temperature [Krebs et al., 2007; Shnyrov et al., 2000], 
at low acidic pH [Lai et al., 1996; Lindgren et al., 2005], or under high hydrostatic pressure 
[Cordeiro et al., 2006]. In this study, we used transient thermal denaturation to induce amyloid 
formation [Shnyrov et al., 2000; Cordeiro et al., 2006; Krebs et al., 2007]. TTR was dissolved in 
physiological saline (150 mM NaCl, pH 7.4) and heated above its thermal dissociation/unfolding 
temperature ( 92 °C) [Shnyrov et al., 2000].  This step mimicked the, as yet, poorly understood 
process of spontaneous formation of prion seeds. Amyloid aggregates generated during this thermal 
induction step were then harvested for subsequent incubation with native TTR tetramers under 
physiological conditions. The seeded solution was monitored for signs of prion-like self-replication 
of these amyloid seed from their native counterpart utilizing read-outs of growth kinetics (light 
scattering, PSD, and ThT fluorescence) and capacity for true self-replication/multiplication (single 
particle tracking). In addition, we investigated tinctorial (Thioflavin T), morphological (AFM) and 
structural (infrared spectroscopy) features of self-replicated aggregates, and compared to those of 
aggregates generated at elevated temperatures. 
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5.2a. Growth Kinetics of TTR Amyloid Oligomer (aO) and Curvilinear Fibril (CF) Seeds  
 
 
 TTR aOs and CFs were generated by incubating 18 µM TTR at 92 °C in physiological pH 
(pH 7.4, 75 mM NaCl).  Aggregation was monitored using light scattering intensity (Figure 5.1a), 
particle size distributions derived from DLS (Figure 5.1b), and relative scattering intensities 
associated with distinct aggregates peaks (Figure 5.1c).  
 
       	  
Figure  5.1. Growth Kinetics of TTR  aOs and CFs at Physiological pH 7.4. 
(a) Light scattering intensity (●) and ThT fluorescence emission (●) increase measured from (18 µM) TTR 
sample (pH 7.4 150 mM NaCl) incubated for 3 hours at 92oC. (b) Changes in hydrodynamic radii (RH ) of 
the same sample representing TTR tetramers (o) and amyloid CFs (■). (c) The CF peak intensity of aO/CFs 
(■) grows at the expense of the tetramer peak (o). 
 
For a typical sample, scattering intensity increased more than two and a half fold within three hour 
of incubation period (Figure 5.1a). CFs were detected after about 1hour of incubation period, as 
indicated by the emerging of a distinct aggregate population with a peak hydrodynamic radius 
around 15-25 nm (Figure 5.1b). In addition, relative scattering intensity associated with the CF peak 
grew at the expense of the original tetramer peak (Figure 5.1c). The growth characteristics observed 
via SLS and DLS were comparable to those described for lysozyme aOs and CFs grown at either 
pH 2 or pH 7, as discussed in chapter 3 and 4. The lag phase in the scattering intensity observed 
during TTR growth (Figure 5.1a) was absent from lysozyme aO/CF growth. Lysozyme aOs consist 
of about eight monomers [Hill et al., 2009], while early TTR aOs are believed to contain only a few 
  (a)                                                    (b)                                                (c) 
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monomeric subunits [Reixach et al., 2004, Faria et al., 2015]. Therefore, native tetramers and early-
state aOs of TTR would have comparable sizes. 
As a result, the transformation of native homotetramers into aOs would leave static light scattering 
intensities unchanged. The lack of lag phase in ThT fluorescence kinetics confirmed steady 
formation of early stage aOs even in the absence of light scattering increase (Figure. 5.1a). 
 
                
 
 
Figure 5.2. Morphological and Tinctorial Characterization of aOs/CFs Generated at Elevated 
Temperatures. (a) ThT fluorescence of samples before (---) and after (___) incubation at 92oC for 3hr. (b) 
AFM image of aOs/CFs seeds grown at elevated temperature. (scale bar: 200 nm; false color scale: height in 
nm) 
 
The significant augmentation of ThT fluorescence from TTR solutions following transient heating 
confirms the amyloidogenic character of TTR aggregates, and their stability after return into room 
temperature (Figure 5.2a). AFM images of these aggregates displayed morphology typically 
associated with aO/CFs (Figure 5.2b) [Pires et al., 2012; Kodali et al., 2007]. 
 
5.2.b.  TTR Amyloid Seeds Self-replicate from Native TTR near Physiological Conditions 
 We set to investigate whether TTR aOs/CFs can induce growth of native TTR at 
physiological temperatures and pH. To begin with, TTR aO/CFs grown via thermal denaturation 
were isolated from residual TTR tetramers and monomers using 100 kDa molecular weight cut-off 
(a)                                                  (b) 
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filters (for details see materials and methods). Successful separation was confirmed using DLS.  
Isolated aO/CFs (20% v/v) were incubated with natively folded TTR (80% v/v) under the 
conditions used for seed formation, but with the temperature maintained at 37°C throughout.  AOs 
and CFs seeded into fresh TTR tetramers, readily induced aggregation of native TTR solutions. 
Scattering intensity showed significant enhancement (almost doubled) within 80 h of incubation 
(Figure 5.3a), while the hydrodynamic radius of CFs increased only marginally (Figure5.3b).  
 
            
 
Figure 5.3. Self-replication of TTR aOs/ CFs from Native TTR Tetramers.  Isolated TTR CFs seeds (3.6 
µM) were added to 18 µM of native TTR tetramers at pH 7.4, 37oC and 75 mM NaCl (a) Increase in 
scattering intensity during 80 hours of incubation. (b) Hydrodynamic radii of native tetramers (o) or CFs 
(■)during incubation. 
 
 
5.2.c. TTR aOs/CFs and Native Tetramers Remain Stable at 37 °C: Growth Requires Seeding of 
Native TTR  with aO/CFs 
 A previous study showed that TTR aggregates generated in low acidic solutions lack 
stability when brought near to physiological pH values [Pires et al., 2012]. Similarly, tau fibrils 
grown at elevated temperatures dissociated upon return to physiological temperatures, unless 
heparin was added as a stabilizing co-factor [Luo et al., 2013].  Initially, we investigated how 
lowering the solution temperature from above the onset for tetramer denaturation (92 °C) [Shnyrov 
et al., 2000] to physiological values (37 °C) affected the stability of the TTR amyloid species 
   (a)                                                          (b) 
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generated at pH 7 and 75 mM NaCl solution. Steady solubility and lack of dissociation of TTR 
aggregates at physiological temperatures is a prerequisite for their ability to propagate within 
tissues and seed new amyloid formation there. Isolated TTR aOs and CFs were re-suspended in the 
pH 7.4 buffer and maintained at 37oC.  
 
 
 
 
 
 
Figure 5.4. Stability of TTR Amyloid Seeds and Native Tetramers at T=37 °C. (a-b) CF seeds, isolated 
from tetramers when brought from 92 to 37 °C, equilibrate to a steady-state plateau as indicated by (a) their 
light scattering intensity Iscat or their (b) hydrodynamic radius RH. TTR tetramers incubated at pH 7.4, 37 °C 
(50 mM PBS, 150mM NaCl) show no sign of aggregation for sixteen days, as indicated by (c) Iscat or (d) RH. 
 
No discernible sign of fragmentation and/or dissociation was observed for more than 24 hr of 
incubation period (Figure 5.4). Seeds stability is confirmed by lack of changes of either scattering 
(a)                                                     (b) 
(c) (d) 
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intensity (Figure 5.4a) and/or hydrodynamic radii (Figure 5.4b). To ensure that TTR tetramers do 
not self-assemble spontaneously when incubated under near physiological conditions, we incubated 
native TTR solution at 37oC for more than 2 weeks. TTR tetramers displayed no signs of 
aggregation. Lack of growth is documented by both lack of increases in scattering intensity (Figure 
5.4c) or hydrodynamic radius (Figure 5.4d). The above-mentioned control experiments confirm that 
neither aOs/RFs nor TTR tetramers could grow themselves, but seeded growth presented above 
(Figure 5.3), requires both native tetramers and aOs/CFs. 
 
5.2.d. Prion-like Proliferation of TTR aOs/CFs from Native Tetramers 
          The above data (Figures 5.3 & 5.4) confirms that TTR aO/CFs are able to grow from native 
TTR tetramers at physiological temperature and pH. The observed enhancement in scattering 
intensity with marginal increases in aggregate size (Figure 5.3) is consistent with the idea of prion-
like self-replication. The lack of increases in aggregates size (elongation) and significant 
enhancement in scattered intensity is consistent with proliferation in aggregates’ numbers, which is 
an important aspect of prion like behavior. To obtain a direct confirmation of prion-like 
proliferation we used single-particle counting/tracking [Filipe et al., 2010]. Using nanosight single 
particle tracking microscope (NTA) we quantified the changes in aggregate numbers during the 
aggregation process. Figure 5.5 a and b display a screen shot of the aggregates present in solution, 
after diluting solutions by a fixed ratio into the range suitable for single particle counting/tracking 
(106-108 particles/ml). The number of aggregates significantly increased with incubation period as 
indicated by the dark-field images (Figs. 5.5 a, b). Figure 5.5c quantifies the enhancement in the 
number of aggregates for over 60 hr of incubation period. This increase in aggregates number 
closely matched the near-linear enhancement in scattered intensity measured prior to dilution. 
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Significant increases in scattering intensity, modest increases in the size of aggregates, and 
significant enhancement in the number of aggregates together confirm that the observed 
aggregation process is indeed prion-like. Hence, this data suggests that the TTR seeded growth 
under physiological pH and temperature is dominated by the self-replication of TTR aOs/CFs from 
native tetramers instead of CFs elongation.     
(a) 
 
                 (c) 
 
(b) 
 
 
Figure 5.5. Self-replication of TTR aOs/CFs from Native Tetramers.   
Isolated TTR CFs seeds (9 µM) were added to 36 µM of native TTR tetramers at pH 7.4, 37oC and 75 mM 
NaCl. Dark-field images of CFs (a) at the beginning and (b) the end of the incubation period.  (c) CFs 
concentration ( ) increases during 66 hours of incubation period. TTR solution is diluted 2,000-fold for 
single-particle tracking measurements. The corresponding scattering intensities measured prior to dilution 
(ο) correlate with the increase in aggregate numbers.  
 
 
5.2.e. Seeds and Self-replicated Aggregates Share Characteristics of CFs 
 Dynamic light scattering and single particle tracking data suggests that TTR aOs/CFs self-
replicate from native tetramers (Figures 5.3 & 5.5). We compared the tinctorial, morphological, and 
structural characteristics of aggregates generated via prion-like self-replication with those of their 
original aOs/CFs seeds to confirm this basic feature of prion-like self-replication. Figure 5.6a shows 
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AFM images of TTR oligomers/CFs used for seeding experiment and the morphologies of the 
resulting aggregates formed after incubation with native TTR at 37 °C for 3 weeks (Figure 5.6b)  
 
          
 
 
Figure 5.6. Morphological and Tinctorial Characteristics of aOs/CFs Obtained via Prion-like Self-
replication at near Physiological Conditions. (a) AFM images of TTR CF seeds and (b) CFs images of 
seeded TTR after 3 weeks of incubation period (pH 7.4, 75 mM NaCl & 37 °C). (Scale bar: 200 nm; false 
color scale: height in nm).  (c) Enhancement in ThT fluorescence emission during prion-like self-replication 
growth of  seeded TTR initialy (---), and after 3 week of incubation period (__). 
 
 
AOs/CFs grown via prion-like self-replication display the same morphology as CFs, grown at 
elevated temperatures. AOs/CFs generated via prion-like self-replication at 37 °C also had 
increased ThT fluorescence (Figure 5.6c) just as aOs/CFs grown under denatured conditions 
(Figure 5.2a). The above kinetic, morphological, tinctorial, and structural characteristics confirm 
that aggregates formed near physiological conditions via seeding of native TTR with aOs/CFs are 
indistinguishable from aOs/CFs seeds grown under denatured conditions. Therefore, TTR aOs or 
CFs, when stabilized at 37 °C, do indeed undergo prion-like self-replication from native TTR. 
 
 
 
 
 
(a)                                          (b)                                                               (c) 
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5.2.f. Structural Characterization of TTR aOs/CFs Grown via Prion-like Self-replication 
 
 A cross β-sheet structure is yet another basic characteristic of amyloids [Zandomeneghi 
et al., 2004]. Using FTIR we analyzed the secondary structure of aOs/CFs grown via prion-like self-
replication. The infrared (IR) absorption from moderate amount of TTR aggregates grown at low 
protein concentration (1 mg/ml) was not sufficient.  In the need to modify our protocol, initially we 
investigated whether prion-like self-replication hypothesis could be tested at 70 oC. If the prion-like 
characteristics are valid at pH 7, this will permit us to generate more aggregated material for FTIR 
study. Initially, we confirmed that growth under these conditions preserved its prion-like 
characteristics with the absence of any spontaneous growth of native TTR tetramers and the 
requirement for seeding by aO/CFs grown at 92 °C (Figure 5.7a). Seeded growth at 70 oC also 
resulted in a significant increase in ThT fluorescence emission while native TTR incubated under 
the same conditions showed no change (Figure 5.7b). Lack of aggregation of native TTR at 70 oC is 
also documented by lack of changes in ThT fluorescence (Figure 5.7b). In contrast, TTR sample 
seeded with 30% (v/v) isolated oligomers/CFS seeds show immediate growth, as is indicated by 
significant changes in scattering intensity (Figure 5.7a). Therefore, we modified our FTIR protocol 
by increasing the protein concentration up to 12.75 mg/ml and raising the incubation temperature. 
Furthermore, highly concentrated TTR samples (12.75 mg/ml) prepared for the subsequent FTIR 
study preserved their CFs morphology (Figure 5.7d). FTIR spectra of TTR aOs/CFs formed at 92 
°C for 2hr and 2 days at 70oC, displayed significant difference in their Amide-I band when 
compared to those of native tetramers. In addition, a structural evolution as a function of incubation 
period at 70oC was observed (Figure 5.7c). TTR aggregates emerging at the late stages of 
incubation at 92oC and 70 °C displayed increases in non-native β-sheet content between 1613 and 
1618 cm−1 and decreases in their percentage of native β-sheet content (∼1630 cm−1) ( Figure 5.7c). 
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The 1613-1618 cm-1  of wavenumbers is considered diagnostic for β-sheet formation associated 
with amyloid fibril growth [Corderio et al., 2006; Zandomenghi et al., 2004; Krebs et al., 2007]. 
The non- native β-sheet increase at the expense of native β-sheet at 70oC, indicates that the growth 
observed under these conditions occurs via prion-like self-replication. 
 
                
 
 
          
 
Figure 5.7. Structural Evolution of Self-replicated TTR Aggregates. (a) Light scattering increases from 
solutions of native TTR (18 µM ) seeded with 30% (v.v) TTR aO/CFs (●) when inubated at 70 0C (pH 7.4 , 
75 mM NaCl), vs. control of unseeded native TTR (o); (b) ThT emission spectra of fresh 18 µM native TTR 
before (----), and after incubation (__) at 70oC for about 90hr, compared to the increase in ThT intensity of  
seeded TTR with aOs/CFs seeds initially (---) and after 45 hr of incubation period  at 70 oC (__). (c) Infrared 
spectra of the Amide-I band indicate the structural evolution of TTR aggregates generated during prion-like 
self-replication at 70oC after 2 days (blue dotted line) or 3 days (black dotted line) of incubation, compared 
to native TTR  under the same solution conditions (solid black line) (d) TEM image of 12.75 mg/ml TTR, 
incubated at 92 oC for 2 hr, and at 70 oC for 3 days. Black scale bar indicates 100nm. 
 
 
 
 
    (a)                                                       (b) 
(c)                                                       (d)                                             
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5.2.g. TTR Stabilizer-Flufenamic Acid Inhibits Prion-like Self-replication Growth 
 
 It has been shown that a class of non-steroidal anti-inflammatory drugs stabilizes the native 
tetramers against dissociation into monomers, a prerequisite step in TTR amyloid formation 
[Schneider et al., 2001]. We tested whether tetramer dissociation is also prerequisite of the prion-
like self-replication growth. Upon adding 40µM of flufenamic acid to seeded TTR solutions no 
growth was observed. Lack of the growth is confirmed by a lack of enhancement in scattered 
intensity (Figure 5.8a), hydrodynamic radii (Figure 5.8b), and relative peak area percentage (Figure 
5.8c).   
 
           
 
 
Figure 5.8. Flufenamic Acid Inhibits Prion-like Self-replication. Flufenamic acid (40 µM) suppresses 
self-replication of TTR aO/CFs as shown by (a) lack of changes in light scattering intensity Iscat (b) the 
hydrodynamic radius RH , and the lack of discernible changes in relative scattering intensities from either 
peak during 18 hr of incubation period (c).  
 
 
5.3. Summary  
Our in vitro experiments provide strong support for the growing evidence of prion-like self-
replication of amyloid oligomers in neurodegenerative diseases. Our recently developed a two-step 
protocol to assess the capacity of different amyloid aggregate species (aOs, CFs, and RFs) of 
(a)                                             (b)                                                    (c)  
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lysozyme [Mulaj et al., 2014] was extended here to human wild-type TTR. In this two-step 
protocol, we initially induced aOs/CFs seeds formation under near physiological conditions, during 
transient heat denaturation. In the second step, we tested prion-like self-replication of TTR aOs/CFs 
under physiological conditions. The seed formation step mimics the yet poorly understood 
mechanisms promoting spontaneous formation of amyloid aggregates in vivo. More importantly, we 
report that preformed amyloid aOs/CFs can undergo prion-like self-replication from their native 
tetramers under near physiological conditions. Furthermore, our data document the structural, 
morphological, and tinctorial similarities of these self-replicated aggregates with those of their 
aOs/CFs seeds. The capacities for prion-like self-replication and propagation, might represent 
another important distinction in the biological activities of oligomers vs. rigid filament counterparts. 
Our in vitro assay opens up the possibility to gain a detailed mechanistic understanding of the 
biophysical mechanisms leading to prion-like self-replication of amyloid aggregates.  
 
5.4 Materials and Methods 
5.4.a.  Protein and Chemicals 
Lyophilized human Transthyretin (TTR) in 25 mM Na Phosphate, pH 7.5, and 75 mM NaCl was 
purchased from Athens Research and Technology (Athens GA) and used for all experiments. 
Ultrapure grade thioflavin T was obtained from Anaspec (Freemont, CA). All other chemicals were 
purchased from Fisher Scientific (Pittsburgh, PA) and were reagent grade or better. 
 5.4.b.  Preparation and Isolation of Amyloid Seeds 
Typically, TTR was dissolved in 25 mM PBS buffer at pH 7.3-7.5, 75 mM NaCl, and filtered 
consecutively through 220 and 50 nm syringe filters. TTR concentrations were determined from 
UV absorption using a 7.76 x10!𝑀!!𝑐𝑚!! based on a 55-kDa molecular weight of TTR tetramers 
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[Jaarsveld et al. 1973]. For oligomer/CFs formation  solutions were incubated at 92 °C for 1.5−3 h. 
Seeds were separated from TTR tetramers using 100 kDa MW centricon filters, spun at 5000 g, and 
rinsed multiple times with the appropriate growth buffer. A volume of 30− 40 µL of isolated seeds 
in buffer was collected from the top reservoir of the filter, and the seed concentration was 
determined from UV absorption.  
5.4.c.  Aggregate Stability and Seeded Growth Experiments.  
For seeded growth experiments, native TTR solutions were mixed with 10−30% (v/v) of amyloid 
seed solutions and incubated for 10−80 hours. For seed stability experiments, oligomers/CFs were 
added at 10−25% (v/v) to buffer and incubated up to 25 h. For FTIR experiments, native TTR 
solution is re-concentrated up to 8-12.7 mg/ml via filtration with 30 kDa MWCF. Concentration 
was determined again from UV absorption. For seeded experiment in presence of flufenamic acid, 
1.4mM of flufenamic acid was disolved in DMSO. A volume of 3 uL of flufenamic acid (1.4 mM) 
is mixed with 97 uL of TTR (18uM).  
5.4.d. Transmission electron microscopy (TEM) 
For TEM images, 12.7 mg/mL TTR solution was diluted 200-fold in distilled water and then 
deposited onto carbon-coated grids. After drying for 3–5 minutes samples were negatively stained 
with 0.5% aqueous uranyl acetate solution. Samples were imaged with a FEI Morgagni TEM at 
60kV using an Olympus MegaView III camera. 
5.4.e. Nanoparticle Tracking Analysis (NTA) 
NTA measurements were performed with a NanoSight LM14 microscope set up (Malvern 
Instruments Ltd. United Kingdom), equipped with a sample chamber with a 405 nm laser and a 
maximum power of 65 mW. The samples were injected in the sample chamber with syringes or 
peristaltic pump (Gilson minipuls 3) until the liquid reached the tip of the nozzle. All measurements 
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were performed at room temperature. The manufacturer’s software was used for capturing and 
analyzing the data (Nanosight NTA 3.1, Build 3.1.46). The TTR sample was diluted 1000 folds 
prior to measurements, and measured for 60 s with manual shutter and gain adjustments. Capture 
and analysis settings were maintained fixed for all measurements. Each data point represent an 
average of 3-5 measurements. The error bars displayed on the number of particles plot were 
obtained by the standard deviation of the different measurements of each sample.  
Summarized description regarding the SLS, DLS, ThT fluorescence spectroscopy, and AFM 
is provided in section 3.4. 
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Chapter 6 
Beta2-microglobulibn (β2-m) and Prion-like Hypothesis 
 
6.1. Introduction	  
β2-m is a 99-aminoacid long protein with a molecular weight of about 12 kDa. Amyloid 
fibrils of β2-m are deposited in patients with dialysis-related amyloidosis. Therefore, β2-m 
represents another biomedically relevant model system for studying the molecular mechanisms of 
amyloid fibril formation. Depending on the in vitro growth solution conditions (pH, NaCl 
concentration), β2-m will form fibrilar structures with different morphologies [Gosal et al., 2005; 
Radford et al., 2005]. RFs of wild-type β2-m can form easily in highly acidic solutions where the 
protein is partially or fully unfolded [Naiki et al., 1997; Kardos et al., 2005]. In vitro amyloid fibril 
formation of β2-m at neutral pH typically requires imposing “non-physiological” conditions, such 
as addition of organic solvents, or cooper ions, or a combination of heating and mechanical 
agitation [Morgan et al., 2011; Yamamoto et al., 2011; Sasahara et al., 2007]. Our hypothesis that 
amyloid aggregates, once formed, might be able to self-propagate in the absence of continued 
denaturing conditions could help to elucidate the relevant mechanism of amyloid propagation in 
vivo. 
In the previous chapters, we have detailed how lysozyme and TTR oligomers and CFs are 
capable of prion-like self-replication from their native counterparts near physiological solution 
conditions. We intended to extend our investigation to determine whether prion-like self-replication 
of amyloid oligomers from their native substrate represents a “generic” phenomenon or an isolated 
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curiosity. Using our previously described two steps protocol, we generated β2-m seeds via heat-
shocking and tested seeds stability and their potential to self-replicate from native monomers near 
physiological conditions. Upon thermal denaturation at physiological pH, β2-m generates 
aggregates that enhance ThT fluorescence and which remain soluble and stable at 370C. We 
investigated the potential for prion-like self-replication of these seeds under near physiological 
conditions. Our preliminary data suggests that aggregates (seeds) generated at pH 7 have distinct 
morphology compared to those of aOs/CFs and RFs. Therefore, we modified our protocol of seed 
aggregation by focusing on conditions where β2-m forms established amyloid aggregates species 
including RFs, aOs and CFs [Gosal et al., 2005; Radford et al., 2005]. We proceed to test the prion-
like behavior of these distinct amyloid aggregates (aOs/CFs, vs. RFs).  
6.2. Results and Discussion  
6.2.a. Self-Assembly of   β2-m via Transient Heat-Shocking at Physiological pH 
 
Initially, we determined the thermal denaturation behavior of native β2-m by monitoring the 
emission peak of its intrinsic tryptophan (Trp) fluorescence (Figure 6.1). Tryptophan intrinsic 
fluorescence spectroscopy is used to monitor the unfolding of a protein’s tertiary structure due to 
the environmental sensitivity of its aromatic residues. We attempted to induce the formation of β2-
m amyloid aggregates at physiological pH, by heating β2-m at 65 oC, which is the lower threshold 
for the onset of partial denaturation (Figure 6.1). The growth kinetics of seed formation was 
monitored via SLS and DLS. Figure 6.2a shows a significant increase in scattering intensity after 
1.5 hr of incubation. This event is associated with formation of aggregates with a size around 70nm 
as indicated in Figure 6.2b.  
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Figure 6.1. Thermal Denaturation Curve of β2-m at pH 7. Wavelengths of peak Trp fluorescence 
emission of β2-m at pH 7  vs. solution temperature. The solid line represents a fit with a two-state model 
through the Trp data.  
 
The amyloid character of these aggregates formed via heat-shocking was confirmed using ThT 
fluorescence, a well-established amyloid indicator dye (Figure 6.2c). The morphologies of the 
resulting aggregates was assessed using AFM (Figure 6.2d). The AFM images indicated that β2-m 
aggregates grown at physiological pH 7 did not have  the expected CFs morphology but were 
spheroids with sizes well beyond that of typical amyloid oligomers. We further tested whether these 
distinctly different aggregates are stable when incubated at physiological temperatures. Most 
importantly we applied our two step protocol to test the ability of these aggregates to self-replicate 
from nativaly folded monomers when incubated under physiological temperatures. 
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Figure 6.2. Growth and Biophysical Characterization of β2-m Aggregates Generated at pH 7 and 
65oC. Nucleation and growth of β2-m aggregates was confirmed by changes in either scattering intensity (a), 
and temporal evolution in PSD (b). (c) β2-m aggregates generated at elevated temperatures (65oC) enhanced 
ThT emission intensity as indicated by initial (----) and final (___) ThT spectra. (d) β2-m aggregates grown at 
physiological pH 7 displayed spherical/ellipsoidal geometries with sizes well beyond that of typical 
oligomers. (scale bar: 250nm; false color scale: height in nm). 
 
      (a)                                                                       (b) 
     (c)                                                 (d) 
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6.2.b. Stability of  β2-m Seeds at Physiological pH and Temperature 
Prior to performing the seeding experiment, we needed to establish whether seeds remained 
intact upon return to physiological temperatures. Using a combination of DLS and ThT 
fluorescence, we investigated whether β2-m aggregates either dissolve or self-associate when 
lowering the solution temperature from above the onset for aggregates formation to physiological 
values (37 °C). To evaluate seed stability in the absence of native monomers, we separated seeds 
from their native protein background using recovery filters (50 kDa), and subsequently re-
suspending them in the same buffer. Successful separation and stability of seeds was determined 
using DLS (Figure 6.3a).  
     
 
Figure 6.3. Stability of β2-m Seeds  at Physiological Temperatures. Seeds stability is tested after 
mechnical seperation from monomeric backround and re-suspension of 20% (v.v) seeds in pH 7 HEPES 
buffer at 37oC. (a) Hydrodynamic radius of isolated seeds measured just after seperation (●) or after 24 hr of 
incubation at 37 oC  (●) . (b) Respective ThT emission spectra of isolated seeds measured initially (●) or 
after 24 hr incubation period  (●). 
 
 
6.2.c. Seeds Grown at pH 7 do not Self-replicate from Natively Folded Monomers 
After the growth and characterization of amyloid seeds at elevated temperatures, and their 
stability at physiological temperatures we tested whether β2-m amyloid aggregates could induce 
  (a)                                                                      (b) 
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fresh amyloid growth when added to their native counterpart at physiological temperature. These 
larger seed were not capable of growth in the presence of β2-m monomers when incubated at 
physiological temperature. Lack of prion-like self-replication is documented by lack of changes in 
scattering intensity (Figure 6.4a) and ThT emission (Figure 6.4b). We presume that the inability of 
β2-m seeds to self-replicate from native monomers has to do with the morphology of the above-
mentioned seeds. 
 
    
Figure 6.4. β-2m Aggregates Grown at pH 7 do not Grow in the Presence of Native Monomers at 
Physiological Temperatures. Lack of growth is confirmed by lack of enhancement in either static light 
scattering (a) or ThT emission intensity (b) measured just before incubation (●) or after 53 hr of incubation 
period at 37 oC (●). 
 
6.2.d.  Growth of  β2-m aggregates with Distinct Morphologies at pH 3.5 
It has been shown that depending on the in vitro growth solution conditions (pH, NaCl 
concentration), β2-m will form fibrilar structures with different morphologies [Gosal et. al 2005; 
Radford et. al 2005]. To confirm the amyloid character of aOs/CFs and RFs seeds formed under 
low acidic pH, we determined their   tinctorial and morphological characteristics.  
(a)                                                                       (b) 
 
 
83	  
	  
 
     
                                      
 
Figure 6.5. Growth Kinetics and Morphology of β2-m Aggregates Generated at  Acidic pH Values. 
Fraction of enhancment of ThT fluorescence for (a) aOs and CFs (1 mg/ml β2-m incubated at 40 oC, pH 3.5 
and 150 mM NaCl); or (b) RFs (0.3 mg/ml β2-m incubated at 40 oC, pH 2 and 0 mM NaCl  with a constant 
stirring); (c) AFM image of oligomers and CFs grown from panel (a); (d) AFM image of RFs grown from 
panel (b). (scale bar: 200nm; false color: height in nm). 
 
Figure 6.5 displays the growth kinetics of aOs and CFs (Figure 6.5a) or RFs (Figure 6.5b) 
monitored via ThT fluorescence. Figure 6.5a documents a typical growth behavior of aOs and CFs 
associated with spontaneous formation of oligomers without any lag phase (Figure 6.5a). In 
contrast, rigid fibrils display a significant lag period, associated with a typical nucleation event 
occurring after 25 hr of incubation period (Figure 6.5b). The morphologies of aOs/CFs and RFs are 
shown in Figures 6.5c and 6.5d respectively. We tested whether these amyloid species would 
undergo prion-like behavior. However, under above-mentioned acidic conditions β2-m monomers 
were partially or completely unfolded as confirmed via Tryptophan fluorescence measurements. 
(a)                                                       (b) 
 (c)                                                       (d) 
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Figure 6.6 displays the thermal denaturation profile of β2-m at three different pH values indicating 
that β2-m is partially or completely unfolded at low acidic solution conditions (pH 3.5 & 4.5) even 
at room temperatures. The solid line in Figure 6.6 represents a fit with a two-state model through 
the Trp data with midpoints for pH 4.5 and 5 at 36.5 oC and 48 oC respectively. 
 
Figure 6.6. Thermal Denaturation Curve of β2-m at Different pH Values. Wavelengths of maximal β-
2m's intrinsic Trp fluorescence emission at pH 5.0  ( ●), pH 4.5 (■) and pH 3.5 (ο) vs. temperature. The solid 
lines represent a fit with a two-state model through the Trp data. 
 
 Initially, we attempted to re-solubilized amyloid aggregates preformed at low pH in  
physiological pH and test their prion-like behavior. However, β2-m aggregates irreversibly 
precipitated at pH 7.   Precipitation might occur due to the pH change across the isoelectric point, 
which for β-2 m stands between pH 5.3 and pH 5.7 [Argiles et al., 1995].  However, the above 
denaturation profiles suggested that we could test “prion-like hypothesis” at pH 5 and room 
temperature, where the β2-m retains its natively folded state. Therefore, we generated amyloid aOs, 
CFs and RFs under low acidic condition solution (pH 3.5), isolate them as described above, and 
cross seed them into natively folded β2-m at pH 5 and 25 oC.  
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6.2.e. Stability of  β2-m monomers and Pre-Aggregated Seeds at Native Solution Conditions                                                                
Since β2-m is partially or completely unfolded under low acidic pH conditions, we could not test 
the “prion-like hypothesis” under the same solution conditions that seeds were generated. 
Therefore, we stabilized seeds at pH 5.0, where the protein remains natively folded. Seeds were 
mechanically separated from monomers via 50 kDa MWCF prior to re-suspension in pH 5.0 buffer. 
Lack of growth or dissociation of aOs/CFs, and RFs at pH 5 is demonstrated via static light 
scattering. Figure 6.7a shows the stability of isolated aOs/CFs at pH 5.0.  
          
Figure 6.7. Stability of β2-m Seeds and Monomers at pH 5. Scattered Intensity vs. incubation period of 
isolated aOs/CFs (0.4 mg/ml) (a), RFs (0.5 mg/ml) (b), and  monomeric β2-m (c) at pH 5.0 and 25oC, 
indicating seed (a&b)  and monomers (c)  stability incubated under above-mentioned growth conditions. 
 
Figure 6.7b documents stability of RFs grown at pH 2 and re-suspended in pH 5.0 buffer. In 
addition, we explored whether monomeric β2-m displayed any sign of spontaneous self-assembly at 
pH 5.0. For that purpose, monomeric β2-m was incubated at 25 oC, pH 5 and monitored 
continuously using SLS. No sign of growth was observed for nearly two weeks of incubation period 
(Figure 6.7c).     
6.2.f. β2-m Amyloid Oligomers (aOs) and Curvilinear Fibrils (CFs) but not Rigid Fibrils (RFs) 
induce Growth via Prion-like Self-replication 
 
  The above stability of amyloid seeds is a pre-requisite for possible prion-like self-
replication from natively folded monomers. Here we tested the potential of prion-like self-
    (a)                                                (b)                                                (c) 
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replication of these distinct aggregates from natively folded monomers. Amyloid seeds of either 
type were diluted 10-fold into solutions of native β2-m maintaining temperature at 25 °C and pH 
5.0. As confirmed from SLS data (Figure 6.8a), amyloid RFs  seeded into fresh monomers showed 
no discernible signs of growth at 25 °C over 30 hours  of incubation period.   
 
            
 
Figure 6.8. β2-m aOs/CFs but not RFs Induce Growth via Prion-like Self-replication. (a) SLS  vs. 
incubation time plott indicating that RFs (10% v.v) can't utilize native β2-m  as substrate for continued 
growth at room temperatures. (b) Oligomers/CFs (10% v.v) readily induced aggregation of native β-2m 
solutions as indicated by the fractional enhancment in ThT emission intensity ( ) or scattered intensity (●). 
All measurements were preformed at pH 5 and room temperature. 
 
This indicates that RFs can't utilize native β2-m as substrate for continued growth at room 
temperatures. In stark contrast, aOs and CFs readily induced aggregation of native β-2m solutions 
(Figure 6.8b). Growth kinetics of aOs/CFs via prion-like self-replication was demonstrated by the 
fractional enhancement of either scattered light (right axis) or ThT fluorescence (left axis). Since 
seeds did not self-assemble without native monomers, the observed growth represent self-
replication of aOs/Cfs from their native counterparts (Figures 6.7 & 6.8). 
(a) (b) 
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6.3 Summary  
Beta2-microglobulin is an amyloid protein involved in dialysis-related amyloidosis. In vitro 
amyloid fibril formation of β2-m at neutral pH typically requires imposing “non-physiological” 
conditions, such as addition of organic solvents, or cooper ions, or combination of heating and 
mechanical agitation [Morgan et al. 2011; Yamamoto et al. 2011; Sasahara et al. 2007]. Our 
preliminary data suggests that once formed, aOs/CFs might be able to self-propagate in the absence 
of continued denaturing conditions. Rigid filaments generated at low acidic pH displayed stability 
at pH 5, but they were not able to induce prion-like self-replication from native monomers.	  β2-m 
aggregates grown at physiological pH showed enhancement in ThT emission, but these aggregates 
did not have typical amyloid morphologies and were not capable of self-replication in the presence 
of β2-m monomers at physiological temperatures. Rapid growth at denaturing temperatures vs. their 
lack of growth at native temperatures implies that big aggregates generated at physiological pH as 
well as RFs generated at low acidic pH require denatured monomers as growth substrate. Only 
oligomers and CFs were capable of inducing autocatalytic self-replication from natively folded β2-
m monomers. Prion-like self-replication of oligomers/CFs implies that only a subset of amyloid 
aggregates might have the capability for self-replication required for their prion-like propagation in 
tissue [Prusiner et al., 2012].  
 β2-m is yet another example of amyloid fibril assembly along a variety of different 
pathways, and following distinct assembly mechanism. Distinct assembly mechanisms can become 
dominant not just upon changes in monomer structure but depend on the type of amyloid aggregate 
formed and their specific propensity to interact with various monomeric conformations under 
various solution conditions. Such diversity of mechanisms might help explain the wide variety of 
phenotypes and aggregation behavior reported for both pathological and functional amyloids. 
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6.4. Materials and Methods 
6.4.a. Protein and Chemicals  
Lyophilized β2-m was purchased from Lee Biosulutions (Maryland Heights, MO) and used for all 
experiments. Ultrapure grade thioflavin T was obtained from Anaspec (Freemont, CA). All other 
chemicals were purchased from Fisher Scientific (Pittsburgh, PA) and were reagent grade or better.  
Solutions were prepared using 18 MΩ water from a reverse osmosis unit (Barnstead E-pure, 
Dubuque, IA). 
6.4.b Preparation and Isolation of Amyloid Seeds.  
Typically, β2-m was dissolved initially in 18 MΩ water from a reverse osmosis unit (Barnstead E-
pure, Dubuque, IA). β2-m was diluted to desired concentration in either   20 mM HEPES at pH 7, 
10 mM of sodium citrate at pH 3.5/5, or 25 mM phosphate at pH 2 and filtered consecutively 
through 220 and 50 nm syringe filters. β2-m concentrations were determined from UV absorption 
using a280 = 19.300 M-1 cm−1 [Kihara et al., 2004]. For aggregate formation at pH 7, solutions were 
incubated at 65 °C for 2−3h. At pH 3.5, oligomer/curvilinear fibril formation was induced by 
incubation of β2-m with 150- 250 mM NaCl at 40 °C for 20-30 h. For amyloid RFs growth, 
solutions were incubated at pH 2 with constant stirring for 30−40 h. Seeds were separated from β2-
m monomers using 50 kDa MW centricon filters, spun at 12,000 g, and rinsed multiple times with 
the appropriate growth buffer. 30−40µL of isolated seeds in buffer were collected from the top 
reservoir of the filter, and the seed concentration was determined from UV absorption.  
6.4.c. Aggregate Stability and Seeded Growth Experiments 
For seeded growth experiments, native β2-m solutions were mixed with 5−15% (v/v) of amyloid 
seed solutions and incubated for 15−53 hours. For seed stability experiments, aOs/CFs were added 
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at 0.1 – 0.5 mg/ml to buffer and incubated up to 20 h, and up to 100 h for RFs and 24hr aggregates 
grown at pH 7. For cross-seeding experiments, protofibrils were generated at pH 3.5 and filaments 
at pH 2. Both seeds were separated from monomers and brought to either pH 5 or pH 7. 
Oligomers/CFs at various stages of growth irreversibly precipitated upon buffer exchange at pH 7.  
Summarized description regarding the SLS, DLS, ThT fluorescence spectroscopy, and AFM 
is provided in section 3.4.  
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Part III: Self-Assembly of Polyglutamic Acid (PLE) 
 
Chapter 7 
Different States of Polyglutamic Acid Results in Amyloid Formation with Distinct 
Morphologies 
7.1. Introduction 
 Polyamino acids (PAAs) and their self-assembly into various surface and bulk structures 
have a broad spectrum of biomedical applications, including catalysis of chemical reactions [Carrea 
et al., 2005], functional compounds in heavy metal filtration [Ritchie et al., 1999], carriers of 
controlled drug release [Uhrich et al., 1999; Li, 2002], and gene delivery systems [Itaka et al., 
2010]. Their specific functionality is often linked with the conformation of the monomer or 
aggregate structure these polyamino acids assume. PAAs are simply biopolymers whose 
conformation depends entirely on their physical and chemical environments. They have no specific 
sequence, no unique conformations and much simpler side chain interactions, all of which make 
PAAs excellent models for studying the mechanism of amyloid formation. Amyloid self-assembly 
of PAAs established that the propensity toward amyloid fibril formation by polypeptides originated 
from their backbone and their tendency towards intramolecular hydrogen bonding [Frandrich et al., 
2002]. For example, it has been shown that Poly Glutamic acid (PLE) upon incubation in acidic 
solution conditions can grow amyloid fibrils [Fandrich et al., 2002]. Amyloid formations is also 
explored as promising platform for the self-assembly of biomaterial with novel mechanical, 
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electrical, and optical properties [Smith et al., 2006; Corrigan et al., 2006; Malisauskas et al., 2008 
Fitzpatrick et al., 2013]. The utility of amyloid fibrils as functional biomaterials at multiple length 
scales is further highlighted by the diversity of macroscopic assembly geometries they can assume, 
which include nanotubes, nanoribbons, and micron-sized spherulites [Lu et al., 2003; Adler-
Abramovich et al., 2009; Lashuel et al., 2000; Krebs et al., 2004; Bromley et al., 2005]. 
 In this study, we used PLE as model system to explore the amyloid assembly of PAAs. We 
originally intended to investigate whether and to what extent the intrinsic polydispersity of 
polyamino acids affected their assembly into amyloid structures. The polydispersity of polyamino 
acids is large when compared to the essentially monodispersed proteins and peptides typically used 
for amyloid fibril assembly. We therefore selected two different PLE stocks with nominally 
different levels of polydispersity. We found that the polydispersity could not correlate to 
aggregation propensity of these PLE stocks. Therefore, we investigated conformation of monomeric 
state of these two PLE sources as a possible origin of macroscopic morphologies of PLE 
aggregates. Using a broad range of biophysical approaches, we characterized the tinctorial, 
morphological, structural, and optical features of PLE aggregates obtained from these two different 
sources and  compare/contrast these characteristics to one-another.  This work was published in 
Intrinsically Disordered Proteins, 3:1, 1-12 in 2015. 
7.2. Results and Discussion 
7.2. a. Assembly of PLE into Distinct Aggregates: Spherulites vs. Fibril Bundles 
 We initially intended to investigate the effects of reduced PLE polydispersity on the fibril 
assembly process. Towards that end we used PLE stocks from Alamanda Polymers of multiple 
average molecular weights (MW = 7.5 kDa, 30 kDa and 60 kDa) with a stated polydispersity 
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indicated (PDI) of only 1.01.  For comparison, we used polydisperse PLE (Sigma-Aldrich) with a 
stated molecular weight range of 50-100 kDa. Typical amyloid growth conditions [Fändrich et al., 
2002] were imposed by dissolving lyophilized PLE stocks in 50 mM citrate buffer at  slightly below 
pH 4.0, and incubation at 40°C. Thioflavin T (ThT), a well-known indicator dye for amyloid fibril 
formation was added to PLE solution [LeVine, 1995]. In all cases, we observed the formation of 
visible aggregates within 24-48 hours. However, the microscope images of the aggregates obtained 
from these two PLE stocks display distinct morphologies. PLE aggregates assembled from 
Alamanda PLE yielded spherical aggregates which were of nearly uniform size within a given batch 
(Figure. 7.1a,b,c).    
	  	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	   	  
Figure 7.1. Morphology of Alamanda PLE Aggregates. 
Light microscopy (a,b) and transmission electron microscopy (TEM) (c) images of aggregates grown from 
Alamanda PLE at concentrations of 1 mg/mL at pH 3.6, 50 mM citrate, 40 °C. (a)Bright field image of 
spherical Alamada PLE aggregates. (b) ThT fluorescence images of same aggregates as in (a). (c) TEM 
images of Alamanda PLE aggregates grown under the same conditions; (d) TEM image of nanoscale 
Alamanda PLE spherulites obtained at high driving forces (PLE concentrations > 2 mg/mL). 
(a)                                              (b) 
(c)                                              (d) 
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These results were independent of the average molecular weight of the stock, the incubation 
temperature or salt concentration used for incubation. The spherical aggregates grown with 
Almanda PLE displayed bright ThT fluorescence (Figure 7.1b), suggestive of an underlying 
amyloid-like structural organization. TEM images (Figure 7.1c) yielded the same dense spheroids 
seen in light microscopy but did not reveal any additional structural information. Increasing the 
driving force for aggregation (i.e.  PLE concentration) results in PLE assembly with a size well 
below micron range. A closer inspection with TEM revealed that, PLE spherulite sizes were 
dramatically decreased down to a few tens of nanometers (Figure 7.1d).  
 In contrast, aggregates formed by Sigma PLE showed little organization at the micron scale 
accessible by light microscopy (Figure 7.2 a). Similar to PLE spherulites, ThT fluorescence images 
confirmed that they were likely to have an amyloid-like organization (Figure 7.2b). TEM images 
confirmed that the aggregates were composed of dense bundles of fibrils at the sub-micron scale 
(Fig. 7.2c).  
	  	  	  	  	  	  (a)	   	  	  	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (b)	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  (c)	  
	  	  	   	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure 7.2. Morphology of Sigma PLE Aggregates. 
Light microscopy (a,b) and transmission electron microscopy (TEM) (c) images of aggregates grown from 
Sigma PLE at concentrations of 1 mg/mL at pH 3.6, 50 mM citrate, 40 °C. (a)Bright field image of 
“disordered” Sigma PLE aggregates. (b) Thioflavin T fluorescence images of same aggregates as in (a); (c) 
TEM images of sigma PLE aggregates grown under the same conditions, indicating that “disordered” 
aggregates display fibril morphologies.  
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The morphology of sigma PLE closely resembled prior reports of PLE assemblies under 
comparable growth conditions [Colacu et al., 2008]. These observations indicate that PLE can 
assemble into either the frequently observed bundled amyloid aggregates with little organization at 
the micron scale or uniform spherical aggregates reaching from tens of nanometers to several 
microns in size. We therefore wanted to characterize structural and tinctorial properties of these 
distinct aggregates, and compare/contrast them.  
7.2.b. Growth and Structure of PLE Spherulites 
  Spherulite formation has been reported for a variety of polymers such as synthetic polymers, 
lipids, proteins, and liquid crystals [Krebs et al., 2004; Bromley et al., 1995]. Determination of the 
detailed structural organization of micro meter-sized shperulites represents an experimental 
challenge due to the difficulties to perform high-resolution structural studies on micron-sized 
aggregates [Yagi et al., 2006]. Assembly of ordered spherulites however do display a characteristic 
optical features when observed under crossed polarizer, known as “Maltese Cross” pattern [Rogers 
et al., 2006; Smith et al., 2012; Keller et al., 1995]. The optical birefringence, resulting in a 
“Maltese Cross” pattern for spherulites grown with Alamanda PLE is shown in Figure 7.3a. This 
characteristic birefringence pattern is an indicator of a high level of structural organization within 
spherulites. The well-defined birefringence of spherulites, their formation under conditions that 
promote amyloid fibrils, and their staining by an amyloid indicator dye ThT (Figure 7.1b), all 
suggest that spherulites share amyloid-like structural organization. However, it has been reported 
that ThT also stained non-amyloidoic protein structures, such as collagen fibrils [Morimoto et al., 
2009]. In addition, ThT fluorescence increases sharply with viscosity, which is found to be high 
inside spherulites [Uversky, 2008]. Recent studies have identified a new intrinsic fluorescence 
emission that is strongly augmented upon amyloid formation [Sharpe et al., 2011; Chan et al., 
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2013]. As shown in Figure 7.3b, PLE spherulites do indeed displayed a dramatic enhancement in 
this intrinsic fluorescence emission. Yet our own lab has cast some doubt to whether this intrinsic 
fluorescence is indicative of underlying amyloid structure. 
 Furthermore, we explored the growth kinetics of PLE spherulites using ThT fluorescence. 
Growth kinetics of PLE spherulites has not been characterized previously. In addition to ThT, we 
utilized a combination of SLS and DLS to characterize the growth kinetics of PLE spherulites. 
Figure 7.3c shows a superposition of SLS intensity and ThT fluorescence emission for Alamanda 
PLE solutions (MW = 30 kDa, C = 2mg/ml, pH 4.1) incubated for 24 hours at 37 oC. The inset in 
Figure 7.3c displays the same data plotted on a semi-logarithmic scale. This display highlights that 
under these growth conditions, no discernible lag period is observed, and these two signals (ThT 
and SLS) yield a similar time-course. While scattering intensity to first order is proportional to the 
molecular weight of aggregates [Cummins & Pike, 1973; Berne & Pecora, 1976], ThT fluorescence 
emission increases with the amount of amyloid material formed. Hence, the similarity in the time 
course of these signals is surprising. Similar correlation between ThT emission signal and SLS 
however was observed during amyloid fibril growth by lysozyme. The similarity of these two 
kinetic signals indicates that growth kinetics of PLE spherulites formation is dominated by the rate 
of new amyloid material formation over growth in size of existing aggregates. The light scattering 
and ThT data (Figure 7.3c) indicate that both of these kinetic signals suggest comparable behavior 
regarding the kinetics of PLE spherulites formation.  
 In addition, we analyzed the amyloid characteristics of PLE spherulites by investigating the 
secondary structure of the aggregates via ATR-FTIR. The FTIR spectra of PLE spherulites were 
compared to those of PLE fibril bundles. Figure 7.3d displays the superposition of the Amide I band 
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from PLE spherulites (solid blue line) versus those from freshly prepared monomeric PLE (black 
solid line), and fibril bundles (dot red line) under the same solution conditions.	   
        
     
Figure 7.3. Growth and Characterization of PLE Spherulites via Optical Microscopy and IR 
Spectroscopy.Microscope images of amyloid spherulites grown from Alamanda PLE (7.5 kDa, 1 mg/mL, 
pH 3.6, 50 mM citrate, 0 NaCl) incubated at 40 °C, (a) Same spherulites as in Figure 7.1a imaged between 
crossed polarizers which reveals the Maltese cross. (b) Unstained PLE spherulites display intense intrinsic 
fluorescence emission associated with amyloid fibril formation (excited 380nm, emission 455nm). (c) 
Fraction of enhancement in either scattering intensity (ο) or ThT fluorescence (●) of spherulites over 24 hr 
of incubation period. Inset shows the same data plotted on a semi-log scale, indicating the lack of lag period. 
(d) Amide I band of the FTIR spectra of monomers (dashed black line) and their corresponding spherulites 
(solid blue line) for 7.5 kDa PLE, and Sigma PLE fibril bundles (dot red line). 
 
The monomeric PLE peaks are near 1650 cm-1 and 1713 cm-1, and are within a few wavenumbers 
difference of prior observations regarding the α-helical conformation of PLE monomers [Fulara et 
al., 2010]. The slight difference in the β-sheet peak in our study from the β-sheet reported 
(a)                                                      (b) 
   (c)                                                      (d) 
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previously [Fulara et al., 2010], probably is due to the fact that the previous study used deuterium 
oxide as a solvent. Upon spherulite and fibril formation, prominent new peaks emerge at 1601 cm-1 
and 1732 cm-1 respectively. The 1601 cm-1 peak represents the β-sheet structure in the fibril state for 
this peptide, which is shifted by about 10 cm-1 towards lower wavenumbers compared to amyloid 
fibrils formed by various proteins [Zandomeneghi et al., 2004; Foley et al., 2013]. This shift has 
been shown to be a specific feature of fibrils formed by pure enantiomers of PLE [Fulara et al., 
2011]. The 1713 cm-1 peak in turn, is diagnostic of COOH stretching modes.  As is shown in Figure 
7.3d, the IR spectra of our spherulites closely match the Amide I spectra associated with non-
spherulitic PLE amyloid fibrils. The combination of FTIR, ThT staining, and intrinsic fluorescence 
indicate that the structural organization of PLE spherulites is amyloid-like. Their optical 
birefringence, in addition, indicates the overall sphero-symmetric organization of the amyloid 
structure within the spherulites. Spherulites structures similar to those of PLE have been observed 
with insulin, the Alzheimer-associated peptide A-β, and prion proteins [Krebs et al., 2005; Exley et 
al., 2010; Sigurdson et al., 2006]. 
7.2.c. Dependence of Spherulite Assembly on PLE Concentration 
 ThT fluorescence was utilized to explore the kinetics of PLE aggregation over a wider range 
of PLE concentrations and molecular weight, [Foley et al., 2013; Miti et al., 2015]. Figure 7.4a 
shows a semi-log plot of ThT fluorescence as a function of incubation period for different PLE (7.5 
kDa) concentrations. Lag period depends strongly on PLE concentration. Figure 7.4b displays ThT 
fluorescence vs. incubation period of PLE growth for multiple experimental repeats with two 
different PLE concentrations, indicating a very small variability in the lag period from sample-to-
sample. To predict the growth rates of nucleated spherulites formation, we used the JMAK model 
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for spherulite growth developed by Kolmogorov and Johnson, Mehl and Avrami [Cahn, 1996; Cahn 
1997]. The JMAK model predicts that the time course for a kinetic signal X(t) following 3-
dimensional spherulite growth is given by:  
𝑋 𝑡 = 𝐴 + 𝐵 1− exp 𝑡 − 𝑡!"# 𝜏 !   
In the exponential term, the time constants tlag and τ represent the lag period and growth rate of 
spherulites respectively [Granasy et al., 2005]. A and B represent the indicator-dependent signal 
baseline and plateau. The above prediction was utilized to fit the ThT fluorescence responses during 
PLE spherulites growth (Figure 7.4a). Growth rate (τ) and lag period (τlag) shown in Figure 7.4a for 
different PLE concentration are calculated from the above equation. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  
Figure 7.4. Concentration-Dependence of PLE Spherulite Assembly. (a) Enhancement in ThT 
fluorescence emission at 485 nm (450 nm ex.) during spherulite assembly of Alamanda PLE (7.5 kDa) at the 
indicated PLE concentrations (40° C, pH 3.6, 50 mM NaCl). Solid lines and tlag/τ parameters represent the 
results of fits through the data using the JMAK spherulite growth model discussed in the text. (b) Kinetics 
traces similar to (a) for four identical samples of PLE at 0.5 mg/mL and 0.25 mg/mL, respectively, 
highlighting the high degree of reproducibility of spherulite kinetics. 
 
 
 
(a)                                                                  (b) 
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7.2.d. Dependence of Spherulite Assembly on pH and Temperature 
 PLE undergoes a pH induce helix to coil transition [Myer, 1969; Nilsson & Zhang, 1990; 
Granasy et al., 2005]. We initially confirmed the helix to colil transition of Alamanda PLE 
monomers. The CD spectra for monomeric PLE between pH 3.6 and 6 is shown in Figure 7.5a, 
indicating a typical transition from a predominant α- helical (with a minima at 208 and 222 nm) to a 
random coil conformation (with a minimum near 200 nm), closely matching previous reports 
[Nilsson & Zhang, 1990]. Further, we tested whether Alamanda PLE would self-assemble into 
spherulites in either confirmation (random coil and/or helix). It has been shown that Alamanda PLE 
undergoes the typical cooperative transition from an alpha-helix to a random-coil conformation 
between pH 4.5 and 5.5 [Granasy et al., 2005]. Figure 7.5b display a decrease on spherulites growth 
rate as the solution pH approaches the α-helix conformation. However, the highly cooperative 
helix-coil transition of PLE monomers with pH (Figure. 7.5a) also coincides with a rapid increase 
in PLE net charge. Hence, it is not immediately clear whether the decline in spherulites growth rates 
is dominated by charge effects or by a preference for the α-helical conformation of PLE. We tried 
to uncouple these effects by screening out charge effects using solutions of very high ionic strength. 
When PLE is incubated at pH 6.0 and with salt concentrations, ranging up to several molar of NaCl 
(Figure 7.5c) no discernible ThT response was observed at any salt concentration. Lack of 
spherulites formation under these conditions was confirmed by optical microscopy, with no 
spherulites visible even after two weeks of incubation.  As control, we incubated PLE at pH 4.5, at 
which point it is nearly completely in the α-helix conformation (Figure 7.5a).  ThT only registered 
weak responses over two days of incubation (Figure 7.5c). However, after one week of incubation 
visible spherulites had formed at all salt concentrations. The absence of any spherulites formation at 
pH 6 and the ability to induce fibril formation at pH 4.5 is consistent with the idea that the α-helix 
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formation promotes formation of ordered aggregates.  One issue confounding this interpretation is 
the known shift of the helix-coil transition to more acidic values upon increases in ionic strength 
[Rogers et al., 2006].  Since alkali and halogen ions interfere with UV-CD spectroscopy, we did not 
attempt to untangle these mutual dependences on solution pH and ionic strength.  
	  	  	  	  	  	   	  
	   	   	  	  	  	  	  	  	  	  	   	   	  
Figure 7.5. pH-Dependence of Spherulite Growth. (a) Far UV circular dichroism (CD) spectra of 
Alamanda PLE (7.5 kDa, 1 mg/mL, 37 °C) as function of solution pH as it is indicated in Figure. (b) 
Deceleration in the kinetics of PLE spherulite growth as pH approaches the edge for the alpha-helix 
conformation; (c,d) ThT fluorescence responses from 1 mg/mL solutions of 7.5 kDa PLE incubated at high 
salt concentrations either (c) in the random coil state (pH 6.0) or (d) near the edge of the alpha helical 
conformation (pH 4.5), incubated at two different temperatures: 25 oC and 40 oC. 
 
 Our observations differ from those of Fandrich et al. (2002), who reported that elevated 
temperatures (65 °C) were required to destabilize the α-helix of poly-l-lysine sufficiently in order to 
induce amyloid formation. During our experiments, we noticed, though, that PLE spherulite growth 
rates decreased within increasing solution temperatures. This effect is documented in Figure 7.6a. 
(a)                                                    (b) 
(c)                                                      (d) 
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Using CD spectroscopy, we confirmed that elevated temperatures did indeed disrupt the α-helical 
conformation of PLE and push its monomers towards a random coil conformation (Figure 7.6b).  
However, this destabilization did suppress, instead of promoting spherulite formation. Furthermore, 
we could not find that PLE spherulite formation required a prior transition of monomers to a β-­‐sheet 
conformation. This observation provides additional support for data that the α-helical conformation 
of PLE actually favors amyloid spherulites formation.  
	  	  	  	  	  	   	  	  	  	  
Figure 7.6. Effects of Temperature on Monomer Structure and Spherulite Growth. (a) Self-assembly of 
PLE (0.5 mg/mL, pH 3.6, 50 mM NaCl) into spherulites monitored at three different temperatures using ThT 
(10 µM) as indicator dye.  (b) CD spectra of PLE (0.2 mg/mL, pH = 3.6) vs. temperature. CD spectra 
indicate a gradual transition from α-helix to random coil conformation as temperature increases. 
 
7.2.e. Compact Globule vs. Random Coil Conformation of PLE as Origin of Distinct Assembly       
Behavior 
  The above data (Figures 7.1 - 7.5) provides details regarding the structure, kinetics, and 
dependence on pH, monomer concentration and temperature  of PLE spherulites. However, it is not 
immediately clear why the two different stocks of PLE we used produced aggregates with such  
strikingly dinstinct morphologies. We presumed that molecular weight polydispersity caused the 
differences in aggregates morphologies.  When subjecting the PLE stocks from either manufacturer 
to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) we found that the actual 
(a)                                                          (b) 
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differences in PLE polydispersity of different stocks were modest, at best (Figure 7.7a).  Hence, 
polydispersity differences seemed inadequate to explain the dramatic difference in PLE amyloid 
self-assembly. FTIR spectra of either stock were similarly indistinguishable from each other 
(Figure. 7.7b), suggesting that the two stock materials were not different in their chemistry. 
 
	  	  	  	   	  
Figure 7.7. Polydispersity and Secondary Structure of Native PLE from Different Sources do not 
Explain Their Distinct Aggregation Behavior. (a) SDS-PAGE analysis of Alamanda vs Sigma PLE stocks 
of various average molecular weights. Overall polydispersity of Alamanda PLE, while reduced, was not 
significantly different from Sigma PLE. (b)  FTIR spectra of Sigma vs. Alamanda PLE at pH 7 in deuterium 
oxide reveal no obvious chemical differences between either PLE stock. 
 The size distribution of PLE monomers, however, measured via DLS near pH 7 was 
dramatically different for PLE monomers from these two sources.  While the hydrodynamic radius 
of 60 kDa PLE was slightly below 4 nm, the corresponding radius of 75-150 kDa PLE from Sigma 
was near 10 nm (Figure. 7.8a).  This more than two-fold difference is inconsistent with the scaling 
of the hydrodynamic radius with the square root of the molecular weight, expected for polymers in 
a random coil conformation. Furthermore, this large difference persisted independent of the solution 
pH used to measure monomer radii. We therefore hypothesized that Alamanda PLE was trapped in 
a highly compacted globule state while Sigma PLE assumed a more expanded random coil 
(a)                                                           (b) 
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conformation. Such a coil-globule transition of PLE, mediated by specific ion absorption onto PLE 
monomers, has been recently deduced from changes in PLE solution viscosity upon addition of 
alcohol [Hasuike et al., 2012]. We subjected this hypothesis to two separated tests.  First, we 
attempted to reverse the specific ion absorption onto Alamanda PLE using extensive dialysis. In 
principle, this should recover the expanded random-coil conformation of PLE, therefore increase its 
hydrodynamic radius. As shown in Figure 7.8a, this was indeed observed. The hydrodynamic radius 
of alamnda PLE increased significantly after extensive dialysis. This expanded conformation of 
Alamanda PLE monomers should then result in the formation of disordered amyloid fibril bundles. 
Figure 7.8b displays a TEM image of dialysed Alamanda PLE incubated at pH 3.6. As shown by 
the TEM, incubation of dialysed Alamanda PLE did indeed replicated the typical aggregate 
morphologies observed with Sigma PLE under the same growth conditions.	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   
	  	  	  	  	  	  	  	  	   	  
Figure 7.8. Compact Globule vs. Random Coil Conformation Determined the Morpholgy of PLE 
Aggregates. (a)  In situ particle size distribution of Alamanda (60 kDa, solid line) vs. Sigma PLE (50-100 
kDa, dotted line) dissolved at pH 7 and 400 mM NaCl. The hydrodynamic radius Rh of Alamanda PLE is 
more than a factor of two smaller than that of Sigma PLE.  Extensive dialysis of Alamanda PLE nearly 
doubles its Rh (dashed-dotted line) (b) TEM images of Alamanda PLE aggregates obtained from dialyzed 
PLE monomers incubated at pH 3.6.  
     
     (a)                                                       (b) 
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7.3. Summary  
 Spherulite formation has been reported in variety of systems, from synthetic and  natural 
polymers [Norton et al., 1985; Toda et al., 1993; Hamley, 2010;] up to a variety of proteins [Krebs 
et al., 2004, Bromley et al., 2005]. Spherulite formation also has also been documented in amyloid 
related peptides such as Aβ [Exley et al., 2010], and human prion protein [Sigurdson et al., 2011]. 
The growth kinetics of PLE spherulites formation is dependent on PLE charge and charge 
screening, consistent with PLE fibril growth reported from other groups [Fandrich et al., 2002; 
Colacu et al., 2008 ]. Our experimental data suggests that poly-L-glutamic acid (PLE) assemles into 
highly ordered spherulites. The amyloid character of PLE spherulites is confirmed by ThT 
fluorescence, Amide I signatures of FTIR spectra and intrinsic flourescence, indicating that 
organization of these spherulites involves the same type of structural re-arangement (i.e. same type 
of hydrogen bonds) as those of PLE amyloid fibrils [Fulara et al., 2010; Fulara et al., 2011]. 
Furthermore, our data indicates that the α-helical conformation does not inhibit but, instead 
promotes spherulite formation (Figure 7.6b).  
 Differences in the polydispersity and chemistry between two PLE stocks obtained from 
different sources could not explain their distinct aggregation behaviour. Our observation implies 
that PLE monomers can exist in either a collapsed globular state or random coil conformation. 
Moreover, the collapsed state in turn promotes PLE spherulite formation while random coil 
conformation promotes PLE fibril formation. The evidence for a collaps state and its effects on the 
morphology of PLE aggregates, suggest that changes in monomer conformation provide yet another 
dimension in the parameter space that modifies and controlls amyloid formation. 
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7.4. Materials and Methods  
7.4.a. Chemicals  
Sodium salts of poly-L-glutamic acid (PLE) were purchased either from Alamanda Polymers 
(Huntsville, AL) or from Sigma-Aldrich. Nominal mo-lecular weights of PLE polymers were either 
7.5, 30 or 60 kDa (Alamanda) or 15-50 and 50-100 kDa (Sigma-Aldrich). Stated polydispersy 
indices of Alamanda stocks were 0.01, as determined by gel phase chromatography. Ultrapure 
grade Thioflavin T (ThT) dye was obtained from Anaspec Inc (Fremont, CA).  All other chemicals 
were purchased from Sigma-Aldrich (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA) and were 
reagent grade or better.  Solutions were prepared using 18 MΩ water from a reverse osmosis unit 
(Barnstead E-pure, Dubuque, IA). 
7.4.b. Amyloid Growth with Poly-L-Glutamic Acid (PLE) Stocks 
Solutions of PLE were prepared by dissolving the lyophilized PLE salts in 50 mM citrate buffer 
with pH values between 3.4 and 6.0.  This buffer concentration was sufficient to maintain pH even 
after addition of PLE.  Solution pH was measured using an AR15 pH meter (Fisher Scientific).  
NaCl concentrations were adjusted by addition of dry ingredient or use of concentrated (2M) stock 
solutions.  Prior to measurements, solutions were routinely filtered through 220 nm PVDF syringe 
filters (Fisher Scientific, Pittsburgh, PA) and, for light scattering measurements, additionally 
through 50 nm PES filters (Tisch Scientific, North Bend, OH).  For dialysis, 0.5 mL of an 8 mg/mL 
solution of Alamanda PLE was dialyzed against 15 mL of water with at least 5 exchanges of the 
water over three days.   
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7.4.c.Optical Microscopy 
For optical microscopy, spherulites were re-suspended in solution by gently  inverting growth 
cuvettes multiple times.  Small aliquots were deposited on a microscope cover slip and placed on 
the stage of an inverted research microscope (IX70, Olympus USA, Center Valley, PA).  Images 
were acquired using a 40 × 0.75 NA water immersion objective (UFluor2, Olympus) and recorded 
with either a DSLR camera (EOS Rebel T3, Canon) or an electron-multiplying CCD camera (Ixon 
DV-885K, Andor Technology Ltd., Belfast UK).  ThT fluorescence was excited using a 455 nm 
laser diode (M455L3, Thorlabs, Newton, NJ) and a filter cube with a 445/20 nm bandpass, a 458 
nm dichroic, and a 482/35nm emission filter (Brightline series, Semrock, Rochester, NY).  For 
observations of optical activity, a polarizer was placed above the condenser and the T2 IX-AN 
analyzer was inserted into the optical path below the microscope objective. 
7.4.d. Transmission Electron Microscopy  
Typically 1mg/mL of PLE solution was diluted 10 fold in buffer and then deposited onto carbon-
coated grids.  After drying for 3-5 minutes samples were negatively stained with 0.5% aqueous 
uranyl acetate solu-tion.  Samples were imaged with a FEI Morgagni TEM at 60kV using an 
Olympus MegaView III camera. 
7.4.e. Circular Dichroism Spectroscopy of PLE Solution 
CD measurements were performed on an AVIV Model 215 (Aviv Biomedical, Lakewood, NJ) or a 
Jasco J-815 (Jasco Inc., Easton, MD) CD spectrometer.  Spectra of monomeric 7.5 kDa PLE at 1 
mg/mL (Aviv) or 0.2 mg/mL (Jasco) were collected at 37°C for multiple pH values. Buffer 
concentration was reduced to 10 mM citrate to minimize background absorption. Wavelength scans 
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were acquired between 190 and 260 nm in 1 nm increments. Three scans with 10 seconds 
acquisition times each were averaged.  Averaged buffer spectra were subtracted from the sample 
spectra. Temperature scans were performed between 20 °C and 80 °C in 10°C increments using 0.2 
mg/mL of 7.5 kDa PLE at pH 3.6 in 10mM citrate buffer alone.  Three scans at a rate of 20 
nm/minute were averaged for each buffer and sample. In all cases, buffer spectra were subtracted 
from the corresponding sample spectra. 
7.4.f. Gel Chromatography 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE ) was used to determine 
the polydispersity of PLE stocks from Alamanda Polymers and from Sigma Aldrich for multiple 
average molecular weights. We used 10-20% gradient Tris-tricine gels (Criterion, Bio-Rad) and a 
sodium dodecyl sulfate (SDS) running buffer without glycine.  An aliquot of 3.6 µg/µL of PLE 
solution was mixed 1:2 with Laemmli sample buffer (Bio-Rad) with reducing agent (β-mercapto-
ethanol). Thirty µL of the 1.2µg/µL sample solutions was loaded onto precast gels and run at 
constant voltage (110 V). The gel was rinsed with DI water, then fixed with a 10% acetic acid, 40% 
methanol solution for 30 minutes, and subsequently stained with 1.5M methylene blue solution and 
destained with DI water.  
 Summarized description regarding DLS, SLS and  ThT fluorescence spectroscopy is 
provided in section 3.4. 
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Chaper 8 
Conclusion 
 Using a broad range of biophysical approaches, including SLS, DLS, ThT fluorescence, 
AFM, TEM, NTA, and CD, we have investigated several basic questions of  amyloid fibril 
formation in vitro. Initially, we have studied the ability of HEWL to self-assemble into distinctly 
diferent amyloid aggregates. Specifically, we assesed growth kinetics, tinctorial, structural, and 
morphological characteristics of the aOs, CFs and RFs. In addition, we have explored the capability 
of these distinct amyloid species to self-replicate from native protein near physiological conditions 
in a “prion-like manner”. To study prion-like characteristics of amyloids, we included in our study 
three different “amyloidogenic” and natively folded proteins: lysozyme, transthyretin (TTR) and 
β2-microglobulin (β2-m). Self-assmbly of poly aminoacids (PAAs) was another aspect of this 
research dissertation. Using a broad range of biophysical approaches we have investigated the self-
assemby behaviour of the intrisically disorder polymer PLE. Particularly, we have investigated the 
origin of PLE aggregates with distinct morphologies. 
  We systematically examined the structure and structural evolution of early-stage 
intermediates and late-stage amyloid fibrils formed during in vitro self-assembly of HEWL. We 
utilized a broad range of bioophysical approaches with a specific empahasis on FTIR and thioflavin 
ThT fluorescence to probe the structural evolution of intermediates formed during in vitro fibril 
formation. We found that no descrinible lag phase is observed  during the oligomeric assembly 
pathway, while a significant lag period associate with a typical nucleation event is observed during 
the growth kinetics experiments of RFs. In addition, we documented a subtle diference on these two 
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types of aggregates morphologies. Our AFM images has indicated that RFs are rigid with a 
monomeric thickens and length of few microns, while CFs displayed a curvilinear geometry with an 
oligomeric thicknes. Twards the end, we correlated structural features derived from FTIR and ThT 
against each other, and against the underlying composition of intermediates in these samples, 
obtained independently from SLS, DLS and from AFM. From Amide I of FTIR spectra we 
demonstrated that both rigid filaments and oligomers/CFs display a β-sheet content. More 
importantly, a subtle difference in β-sheet content betweem aOs/CFs and RFs was observed. 
Furthermore, we reported a pathway-specific intrinsic ThT responses,  implying that ThT 
recognized distinct structural motives of intermediates formed along these pathways. All our 
experimental data  has sugessted that there is a tinctoral, structural, and morphological distinction 
between oligomeric-free and oligomeric assembly pathway. 
  Another aspect of this research dissertation was the investigation of prion-like behaviour 
amyloid aggregates. Specifically, we explored  how changing temperature (and pH) from 
denaturing to physiological range affects the stability and potential for self-replication of  distinct 
amyloid aggregates species (aOs, CFs, RFs). Our study focus was on natively folded protein 
associated with human amyloidoses. We combined SLS/DLS, fluorescence spectroscopy, AFM, 
TEM, NTA, and FTIR to explore the stability and prion-like self-replication ability of amyloid 
aggregates grown at elevated temperature after return to physiological temperatures. Initially, we 
explored HEWL and its well known ability to self-assemle into aggregates with distinct structure 
and morphology.	  Our finding has suggested  that lysozyme oligomers, CFs and RFs are stabile at 
physiological temperature and pH. However, we showed that only oligomers and CFs can induce 
prion-like self-replication from native monomers. To investigate whether prion-like self-replication	  
is a generic feature or it is specific related to some proteins, we further extended our work with two 
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other amyloid-related and natively folded proteins: TTR and β2-m. We have reported that TTR aOs 
and CFs similar to those of lysozume’s are stable at physiological temperature, pH and ionic 
strength. Both DLS, ThT flurescence, and NTA data has suggested that  TTR oligomers and CFs 
induced prion-like self-replication from native tetramers. Equally important, the aggregates 
generated near physiological conditions preserve structural and morphological properties of their 
seeds. We further have confirmed that  β2-m aggregates produced under denatured conditions at 
physiological pH displayed a siginficant response in ThT fluorescence, but this aggregates do not 
have RFs or CFs morphology. Instead they show spherical/ellipsoidal geometry with sizes well 
beyond that of typical oligomers. Furthermore, we have documented that these larger aggregates do 
not self-replicate from β2-m monomers at physiological temperatures. However, we have shown 
that aOs/CFs and RFs can be generated under low acidic pH conditions. These seeds are stable in 
higher pH (pH 5) solution where β2-m is natively folded. We, therefore tested the prion-like 
hypothesis by performing cross-seeding experiments from low acidic pH to pH 5. Lastly, we have 
reported that only β2-m aOs and CFs, but not RFs can induce prion-like self-replication from 
natively folded monomers. Our findings suggest that prion-like replication of aOs/CFs is a generic 
feature of these aggregates rather than specific-related to a protein. The above findings about prion-
like self-replication are significant because persistent studies have accounted difficulties of 
identifying amyloid proteins capable of forming fibrils under near-physiological conditions. This 
has raised the broader question of how do these diseases do emerge and propagate under 
physiological conditions. Therefore, our two-steps protocol may help on unrevealing the 
mechanism of amyloid formation under physiological conditions. 
 The amyloid  self-assembly of PAAs is another aspect of this research dissertation. Using 
our above-mentioned  biophysical approches we have reported that intrinsically disordered polymer 
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PLE obtained from different sources	  self-assembled into  morphologicaly distinct aggregates. We 
further investigated the origin of these distinct aggregates (spherulites vs. fibrils). We have shown 
that PLE spherulites share both tinctorial and structural characteristics with their amyloid fibril 
counterparts. More importantly, we have provided  evidence that PLE polymers can exist in either a 
collapsed globule or an extended random coil conformation. Lastly, we have documented that 
collapsed globule consistently produces spherulites while the extended coil assembles into 
disordered fibril bundles. These results suggest that these two PLE conformers directly affect the 
morphology of the resulting macroscopic amyloid assembly.  
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Appendix 1 
 Experimental Techniques 
 
A.1. Dynamic Light Scattering (DLS)  
 DLS is a non-invasive, well-established technique for measuring the size distribution of 
macromolecules and particles typically in the submicron region. DLS can measure sizes of particles 
lower than 1nm by measuring the temporal correlation of fluctuations in scattering intensity. These 
fluctuations	   arise from random thermal (Brownian) motion.	   The fluctuation in the intensity of 
scatter light at the detector reflects the constructive and destructive interference of light scattered by 
the randomly moving particles within the illuminated sample volume.	  DLS measures the temporal 
correlations of these statistical fluctuations in light scattering intensity. If the scattering particles are 
small compared to the inverse scattering wave number (see page 117), the intensity of scattered 
light is not angle dependent and is called Rayleigh scattering.  However, if the particles are large 
compared to vector scattering wave number the intensity is angle dependent and is called Mie 
scattering. 
  In a typical experiment, a photomultiplier will record the number of scattered photons 
arriving within a short interval time. The diffusion coefficient of the particle and their 
hydrodynamic radius can be determined	   by analyzing the time dependence of the intensity 
fluctuations. The auto-correlator in the DLS determines the intensity-intensity autocorrelation 
function given by: 
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( ) ( ) ( )
( ) ( )∫
∫ +=
dttItI
dttItIg ττ2 	  
Where I (t) and I (t+τ) represent recorded intensities at time t and (t+τ) respectively. Delay time is 
represented by τ.  The experimentally measured intensity correlation function is first converted into 
the field correlation g1(τ) function by the Siegert relationship [B. Chu, 1991; W. Brown, 1993; B. J. 
Berne and R. Pecora, 1976]:                                                
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   ( ) 12)(1 −= ττ gg  
For a collection of small particles, it can be shown that g1(τ) is the Laplace transform of the decay 
rates of local concentration fluctuation for the different-sized particles in the given volume : 
( ) ( ) ΓΓ−∫
∞
Γ= deGg ττ
0
1  
Where Γ represents the decay rate for particles of a given size, and G(Γ) is the distribution of  
decay rates. The decay rate Γ, in turn is related to the particle’s diffusivity and the scattering 
geometry of the measurements via: 
Γ=Dq2 
where D is the translational diffusion coefficient and q is the scattering wave vector, given by:  
                                                              q = (4πn/λo) sin(θ/2). 
Where n is the refractive index of the scattering medium, λo is the wavelength of incident light, and 
θ is the angle the scattering is observed at.    
   For spherical particles, the diffusion constant can be related to the radius of the diffusing 
particle and the solution viscosity via the Einstein–Stokes relation [Berne and R. Pecora, 1976; 
Dasgupta et al. 2002; Muschol and Rosenberger 1995] 
Rh = kBT/6πηD 
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where kB is the Boltzman constant, T is the absolute temperature, and η is the viscosity of the 
solution.  
A typical schematic representation of a commercial DLS configuration is shown in Figure A.1.1. It 
consists of a laser which illuminates the sample. Scattered light is measured by the detector at a 
specific angle (Malvern DLS: θ = 173˚). The stream of electronic pulses from the detector passes to 
the digital correlator. The digital correlator generates the intensity-intensity correlation function 
g2(τ), and the software algorithms then determine and invert g1(τ) to obtain the size distribution and 
polydispersity [Source:	  Malvern Instruments]. 
 
 
Figure A.1.1. Schematic Representation of Dynamic Light Scattering set-up. A light beam coming from 
laser illuminates the sample (cell), where the scattered light is detected by the detector at specific angle 
(137o) and passed to the digital correlator for processing by software algorithms [source: Malvern 
Instruments]. 
 
A.2. Static Light Scattering (SLS)  
SLS from macromolecules measures the time-averaged intensity of scattering light due to 
the thermally induced fluctuations of local particle concentrations.  In general, the scattering 
intensity of macromolecular solutions is given by 
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where, P (q) and S (q) are the form and static structure factor of the molecules, which account for 
intraparticle and interparticle interference effects respectively, n is the solvent refractive index, M is 
the molecular weight of the solute (protein), dn/dcp the refractive index increment of the solution 
due to the protein, cp is the protein’s concentration , NA is Avogadro’s constant, R is the distance 
between the origin of the scattering volume and the detector, λ is the wavelength of the incident 
light, and q is the scattering wave number given by 
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Our macromolecule systems are Rayleigh scatters as their radii are much smaller 1/q. Therefore, P 
(q) = 1. Since, the mean protein spacing d is much less than the wavelength of the light, the 
structure factor S (q=0) can be described by a virial expansion in the solute concentration and the 
corresponding scattering intensity becomes: 
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Where K is an optical constant defined as: 
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In scattering experiments Ii and R are fixed and we measure Is.  These measured quantities can be 
combined into a single quantity called Rayleigh ratio Rθ,	  given by: 
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For interacting particles, Rayleigh ratio Rθ	  is related to properties of the macromolecules in solution 
via: 
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In practice, a reference standard toluene is used to define the Rayleigh ratio by   
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where Is denotes the scattering intensity of the sample, Isol is the scattering intensity of the solvent,   
IT is the toluene scattering intensity, no is the solvent refractive index, nT is the toluene refractive 
index,  and RT is the known Rayleigh ratio of toluene.  A plot of KCp/Rθ vs. protein concentration 
Cp varies linearly with protein concentration. The molecular weight of the protein can be derived 
from the y-intercept at Cp=0 and values of the second virial coefficients B2 are equal to the slope of 
KCp/Rθ. Positive values of B2 indicate net repulsion whereas negative values of B2 indicate net 
attraction between proteins. 
A.3. Nano Particle Tracking Analyses (NTA) 
 Although DLS is extensively used to characterize nanoparticle sizes, it is known that it has 
several drawbacks, which are mainly intrinsic to the principles of the technique. As we discussed in 
previous section, particle size in DLS is determined from fluctuations in scattered light intensity 
due to the Brownian motion of the particles. The dependence of scattering intensity in molecular 
weight of scatters makes this technique very sensitive to the presence of large particles; therefore, it 
makes very difficult detection of smaller particles in the same solution. Nanoparticle tracking 
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analysis (NTA) is an innovative microscope system, which utilizes the properties of both light 
scattering and Brownian motion in order to obtain the particle size distribution of samples in 
solution. NTA uses a combination of laser light scattering microscopy and a charge-coupled device 
(CCD) camera, which enables the visualization and recording of nanoparticles in solution. A laser 
beam illuminates the particles in suspension, and single particles are visualized undergoing 
Brownian motion, where a video file of the moving particles is recorded. The NTA software tracks 
individual nanoparticles undergoing Brownian motion, and using the Stokes-Einstein equation the 
software relates the movement to a particle’s size. NTA provides high-resolution particle size and 
concentration (number of particles in a given volume) measurements. A typical schematic 
representation of a commercial NTA configuration is shown in Figure A.3.1.  
 
Figure A.3.1. Schematic representation of  NTA. A light beam coming from laser illuminates particles in 
suspension , where the scattering light of single particle is recorded in a video file by CCD camera mount in 
microscope [source: Malvern Instruments]. 
 
A.4. Atomic Force Microscopy (AFM)  
  AFM is a mechanical imaging technique capable not only of obtaining high-resolution 
three-dimensional topographical images, but also of determining certain physical properties of 
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imaged surfaces, such as their mechanical properties and composition.  AFM, in particular, has 
attracted the attention of biologists since it theoretically combines the two most important aspects 
for studying structure-function relationships of biological systems. AFM possess a variety of 
advantages compare to other imaging techniques. Among advantages are included high-resolution 
imaging with high signal to noise ratio, and its ability to operate in aqueous environments. The 
ability to operate in solutions allows scientists to explore molecular dynamic events in real time and 
close to physiological conditions. Despite the broad range of advantages, AFM has some 
disadvantages that limits the application of this mechanical imaging technique in other areas. The 
disadvantages include the AFM lateral resolution that is intrinsically dependent on the sample, the 
finite size and shape of the tip, the compression due to the probe force and sometimes-limited 
understanding of tip-sample interactions.  
  AFM does not utilizes optical lenses to generate an image. Instead, at the core of AFM 
instrument is a sharp probe or tip mounted to the end of flexible cantilever arm. The tip is usually 
made from silicon, and it is used to scan the surface of a sample by measuring the forces between 
the sample and the tip. Very small deflections of cantilever in the range of fraction of nanometers 
can be detected. To detect the cantilever deflection, variety of approaches have been employed. The 
most common used approach, called the optical lever reflects a laser beam off the back of the 
cantilever into a quadrant photodiode. The optical lever is essentially a motion amplifier. The 
detection of the laser spot at the photodetector is proportional to the deflection of the cantilever with 
a gain factor. While the tip scans across the surface of interest, the cantilever deflections derived 
from the quadrant photodiode are used to generate a map of the surface topography. A schematic 
representation of a typically commercial AFM is shown in Figure A.4.1.  
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  Depending on the properties of the sample and information to be extracted from it, AFM 
imaging can be divided into static (contact) modes and dynamic (non-contact) modes. Contact 
mode of AFM is mainly used to image hard surfaces when the presence of lateral forces is not 
expected to modify the morphological features. 
      
Figure A.4.1. Schematic Diagram of a Commercial AFM. A laser beam is focused on the cantilever that 
has a highly reflective surface. After the beam is reflected from the cantilever, it is  focused on a quadrant 
photodiode. Small deflection in the cantilever as a result of sample interaction  with the tip generates 
significant displacement in the laser beam on the quadrant photodiode. The cantilever deflections are used to 
generate a map of the surface topography [Figure is adopted from: Morandat et al. Anal Bioanal Chem. 
(2013)]. 
 
In this mode, the deflection or force between the tip and sample is maintained constant by an 
electronic feedback loop. When the tip encounters any obstacle on the surface, the cantilever begins 
to deflect upward or downward. Therefore, any retraction and/or raise of the sample cancel 
deflection of the cantilever, thereby keeping a constant force between the tip and sample. The 
voltage that feedback amplifier applies to the piezo to raise or lower the sample is a measure of the 
height of the sample’s features as a function of the lateral position. In the non-contact mode, the 
cantilever vibrates at its resonance frequency. As the probe approaches the sample, interactions 
such as van der Waals interactions and electrostatic forces occur between atoms in the tip and the 
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sample. This causes a detectable shift in the frequency of cantilever oscillations. These changes in 
the oscillating frequency of the cantilever provide the signal for imaging.  In non-contact mode the 
duration of sample-tip is very short, therefore the destructive effects of lateral forces are 
dramatically reduced. 
A.5. Electron Microscopy 
  Electron microscopy (EM) is another imaging approach for obtaining high-resolution 
images of biological and non-biological systems offering structural information, which are 
complementary and competitive with other techniques such as crystallography, small angle 
scattering (SAS) and NMR. Its high-resolution (0.1-0.3 nm) imaging capability make EM very 
suitable technique for studying biological systems such as	   cells, tissues, organelles and 
macromolecular complexes. EM operates in a similar manner to light microscopy with electrons, 
instead of photons, focused by electromagnetic lenses instead of optic lenses. Electromagnetic 
lenses mounted in electron microscope focuses a beam of electrons, which were accelerated from a 
thermionic triode electron gun.	  The focused electron beam travels along microscope chamber and 
collides with the surface of the sample. The obtained characteristics from EM images are because of 
the interaction of electrons with the electrostatic potential distribution of the atoms in the sample. 
The high resolution of EM images is based on the wave-like behavior of electrons (which have very 
short wavelengths and high velocity) as the source of illuminating radiation [Serdyuk et al., 2007]. 
Two examples of an electron microscope are transmission electron microscope (TEM) and scanning 
electron microscope (SEM). In our study, we used transmission electron microscope (TEM), for 
that we will discuss in the following paragraphs. 
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In a conventional TEM, a thin sample (specimen) is irradiated with an electron beam of high energy 
(between tens of kV up to 1MeV) of uniform current density. Electrons, emitted in the electron gun, 
passes along three or four stage condenser-lens systems permitting variation of the illumination 
aperture and the area of illuminated sample. These electrons interact with sample’s atoms via elastic 
and inelastic scattering. Depending on the sample density and its composition, the thickness of 
specimen for imaging might vary. For instance, for 100 keV electrons, a typical thickness of 
specimen stands in the order of 5-100nm [Reimer and Kohl, 2008]. A very small objective 
apertures in the order of 10-25 mrad achieves a high-resolution imaging (0.1-0.3 nm) due to a great 
value of aberrations of the objective lens. 
 
Figure A.5.1. Schematic view of TEM, and pathway of electrons beam [Source: Figure is 
adopted from http://intranet.tdmu.edu.ua/data]. 
 
TEM forms an image mainly by the interference between the electrons which have passed through 
and interacted with the sample and with those electrons which were not affected by the sample, 
giving a phase contrast image. However, bright field contrast is obtained by interference of 
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scattered wave and incident wave at the image point (phase contrast) or by scattered electrons at 
different angles (scattering contrast). Dark-field contrast is produced by tilting the primary electron 
beam or by hollow-cone illumination, therefore the primary beam falls on the objective diaphragm. 
A fluorescent screen composed of three to eight lenses allows imaging by recording electron 
density distribution behind the specimen [Reimer and Kohl, 2008]. The images are recorded either 
by direct exposure of a photographic emulsion or digitally via the fluorescent screen coupled by a 
fiber-optic plate to a CCD camera. 
A.6. Fourier Transform Infrared Spectroscopy (FTIR) 
 FTIR is a widely employed technique for characterizing the composition and structure of 
organic materials. Molecules absorb specific frequencies that are characteristic of their structure, 
and chemical composition. It identifies specific bonds by molecules stretching or bending vibration. 
In the simplest example of a diatomic molecule, the movement of each molecule toward or away 
each other along the bond direction represents the stretching vibration. A molecule with three or 
more atoms can experience bending vibration, where the angles between individual atoms changes. 
In the case of more than two atoms, stretching vibrations can be either symmetric	  or asymmetric. 
The net dipole moment is constant during symmetric vibration mode, therefore symmetric 
stretching mode is IR-inactive. In stark contrast, the net dipole does vary with the stretching 
vibration in the asymmetric mode; therefore the mode is IR-active, and IR radiation at the 
frequency of this mode can be absorbed, exciting the asymmetric stretching vibration [Serdyuk et 
al., 2007]. The number of independent peaks in a given absorption spectra is reduced	   due to 
repeated units of polypeptides. This gives rise to strong absorption bands. These bands are named 
amide A, amide B, and amide I-IV. Proteins show absorbance in each of these bands, but Amide I 
and Amide II are of particular interest. While the Amide I band is more sensitive indicator of 
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secondary structure, the Amide II band is mostly due to vibrations from in-plane NH bending and 
CN stretching [Kong and Yu, 2007].  
The resulting IR spectrum represents the molecular absorption or transmission, creating a 
molecular fingerprint of the sample. Initially, most infrared spectroscopy was performed by 
dispersive methods using prisms or diffraction gratings. A faster and higher throughput method that 
allows a wide spectrum of IR absorbance to be measured at once has been applied over the recent 
years thanks to increasing in computing power. FTIR spectroscopy uses a wide spectrum infrared 
source, the emission of which passed through a Michelson interferometer. The light is directed 
through the sample and into the IR detector (Figure A.6.1). 
 
Figure A.6.1. Schematic of Bruker Optik Vertex 70 FTIR Spectrometer. The orange color shows the 
optical path from the mid-infrared source into the interferometer, through the sample, and on to the detector. 
[Source:  Bruker Optik Vertex 70 Manual]. 
 
The interferometer components are arranged such that a collimated light source is divided along 
two path lengths, leading to interference. The plot of detected intensity vs. path difference (ΔL) is 
called an interferogram (Figure A.6.2a).	   In the case of monochromatic light as a source with 
wavelength λ, the interferogram is just cosine function with a frequency of 1/λ. For the wide 
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spectrum source used as in case of FTIR measurements, the interferogram is the sum of the 
contributions from each frequency component 1/λ, or wavenumber.  To retrieve the spectral 
information, a Fourier transform is performed, which convert the data from the spatial to the 
frequency domain (Figure A.6.2b). 
 
Figure A.6.2. FTIR Interferogram and Respective Transmission Spectra. An interferogram (a) and the 
corresponding transmission spectrum (b) measured for a lysozyme amyloid fibril sample. (pH 2; 50 mM 
NaCl; incubated at 50 °C). Notice, the presented transmission spectra represents contributions from not only 
the sample, but also any absorption due to water vapor, the buffer solution, and	  optical components. To 
eliminate these undesired contributions, the background spectra before measuring the absorbance spectrum 
of the sample needs to performed [ Source: Figure is generated in our laboratory by Joseph Foley]. 
 
A.7. Circular Dichroism (CD)  
 CD is defined as the difference in absorption between the left circularly and right circularly 
polarized light for a chiral molecules. CD technique is considered as one of the most powerful 
approaches for monitoring structural differences and conformational changes of macromolecules. 
CD plays an important role on revealing the secondary and tertiary structure of proteins. Near-UV 
(260– 320 nm) CD signal is sensitive to tertiary structure of proteins due to absorption of aromatic 
(a) (b) 
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residues in this regime, such as tryptophan and tyrosine. Each of the amino acids tends to have a 
characteristic wavelength profile. For instance, Tryptophan (TrP) shows a peak close to 290 nm; 
Tyrosine (Tyr) peaks between 275 and 282 nm, with a shoulder at longer wavelengths often 
obscured by bands due to Trp; Phenylalanine (Phe) display a band with fine structure between 255 
and 270 nm (Figure A.7.1a). The far-UV CD signal (190-250 nm) as readout of secondary structure 
is primarily driven from peptide backbone of the proteins. For instance, α-helix structures have 
negative peak at 222 nm and 208 nm and β-sheet structure peaks at 218nm (Figure A.7.1b). 
          
Figure A.7.1. The Near and Far UV CD spectra. (a) The near-UV spectra for type II dehydroquinase from 
Streptomyces coelicolor. The wavelength ranges corresponding to signals from Phe, Tyr, and Trp side chains 
are indicated [Adopted from Kerll et al., J. Biol. Chem. 271, (1996)]. (b) Far UV CD spectra associated with 
various types of secondary structure. Solid line, α-helix; long dashed line, anti-parallel β-sheet; dotted line, 
type I β-turn; cross dashed line, extended 310-helix or poly (Pro) II helix; short dashed line, irregular 
structure [Adopted from Kelly et al.	  Biochimica et Biophysica Acta 1751  (2005)]. 
 
A.8. Fluorescence Spectroscopy  
Fluorescence spectroscopy has application in many areas of analytical science due to its high 
sensitivity and selectivity. A molecule absorbs photons from the visible and near UV light 
spectrum, causing transition to a higher-energy electronic state known as excitation (Eex). This is an 
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unstable electronic singlet state (S1') as described by the green arrow in Figure A.8.1a, and has a 
very short lifetime. The excited fluorescent molecule relaxes towards the lowest vibrational energy 
level within the electronic excited state (S1), ‘’loosing’’ the energy (yellow arrow). Fluorescence 
emission originates from the drop from the excited state S1 to the ground state S0 (red arrow). The 
energy of the photon that is emitted in this process (Eem) is exactly the difference between S1 and 
S0. A typical fluorescence spectrum is shown in Figure A.8.1b.  
 
	  	  	    
Figure A.8.1. The Basic Principle of Fluorenscence. a) Excitation from ground state S0 to the excited state 
S1' (green arrow) by absorption of a photon with energy Eex; yellow arrow represent relaxation from S1' to the 
lowest vibrational energy level within the electronic excited state S1; and red arrow represent emission of a 
photon with energy Eem, bringing the fluorescent molecule back to ground state S0. b) A fluorescent 
compound (fluorophore) characterized by excitation (green) and emission (red) spectra. [Source: Figure b is 
adopted from http://www.bio-rad.com/en-al/applications-technologies/detection-methods]. 
 
The	   fluorescent compounds (fluorophore) are characterized by their excitation and emission 
properties. The excitation spectra (green) are determined by measuring the intensity at a fixed 
wavelength, while varying the emission wavelength. The emission spectrum (red) is determined by 
variation in emission intensity wavelength for a fixed wavelength. The difference between 
excitation and emission wavelength is known as Stokes shift.  
(a)                                                         (b) 
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In our study, we used the fluorescence spectroscopy to investigate the unfolding of a protein’s 
tertiary structure (Intrinsic Fluorescence Spectroscopy), and followed amyloid aggregation due to 
changes of fluorescence intensity upon binding of ThT, a dye sensitive to amyloid aggregation 
(Thioflavin T Fluorescence). 
Intrinsic Fluorescence Spectroscopy is a reliable and non- invasive technique to monitor the 
unfolding of a protein’s tertiary structure due to an environment sensitivity of tryptophan (Trp) 
and/or Tyrosine (Tyr) fluorescence. By exciting the Trp/Tyr fluorescence (~280-290 nm) and 
monitoring the shift of the peak in the emission spectrum, one can track the partial unfolding of 
proteins.	  Tryptophan/Tyrosine residues that are exposed to water have maximal fluorescence at 
longer wavelength whereas totally buried residues fluoresce at shorter wavelength. For instance, 
lysozyme contains six tryptophan residues (Trp28, Trp62, Trp63, Trp108, Trp111, and Trp123). For 
lysozyme the tryptophan to tyrosine ratio is high (2: 1), and interference from tyrosine emission 
and/or tyrosine to tryptophan energy transfer is minimal [Imoto et al., 1972]. The majority of the 
emission is coming from Trp62 and Trp108 [Nishimoto, et al., 1998].	  Trp108 is mostly shielded 
from water in native lysozyme, and its emission peak is near 342 nm. Under denaturing conditions, 
the Trp108 residue is exposed and its emission maximum is shifted to longer wavelengths. The 
tryptophan at residue Trp62 however is almost fully exposed, even in the native state, and its 
emission maximum near 352 nm is mostly insensitive to unfolding events. 
 Thioflavin T Fluorescence measures changes in fluorescence emission intensity of ThT upon 
binding to amyloid fibrils, which commonly is used to detect amyloid fibril formation.	  The large 
enhancement of its fluorescence emission upon binding to amyloid makes ThT fluorescence a 
particularly convenient tool for studding assembly kinetics.  ThT-amyloid fibril interactions binding 
parameters are based on the assumption that fluorescence intensity is proportional to the 
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concentration of the bound dye.	  ThT binds to diverse protein fibrils, despite their distinct amino 
acid sequences, suggesting that ThT recognizes a structural feature common among fibrils. Because 
amyloid fibrils share the cross-β architecture, it is generally accepted that the surfaces of cross-β-
sheet structures form the ThT-binding sites [Biancalana et al. 2010]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
